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Abstract 
Male	 infertility	 is	 typically	 diagnosed	 upon	 routine	 semen	 analysis	 following	 the	
World	Health	Organisation’s	(WHO)	semen	analysis	manual.	Recent	editions	of	the	
manual	 have	 essentially	 changed	 the	 diagnosis	 of	 a	 semen	 sample,	 prompting	
debate	between	experts	as	to	which	edition	should	be	followed.		Deoxyribonucleic	
Acid	(DNA)	integrity	analysis	is	proving	to	be	a	useful	adjunct	to	semen	analysis	as	
15%	 of	 infertile	men	 have	 a	 normal	 semen	 analysis	 but	 they	 have	 an	 increased	
DNA	fragmentation	level	(DFL)	which	has	been	associated	with	increased	disease	
incidence	in	any	resultant	offspring.	However,	such	tests	are	not	endorsed	by	the	
WHO,	possibly	due	to	a	lack	of	standardisation	in	the	implementation,	analysis	and	
clinical	 interpretation	 of	 methods	 used	 to	 evaluate	 DNA	 integrity.	 Improved	
efficiency	 of	 testing	 is	 achieved	by	 batch	 testing	 or	 sending	 samples	 to	 a	 central	
laboratory	 for	 analysis,	 requiring	 an	 effective	 storage	 system.	 Most	 current	
protocols	 for	 semen	 storage	 and	 related	 DNA	 integrity	 testing	 are	 complex,	
expensive	and	require	specialised	equipment.	Nevertheless,	since	the	Halosperm®	
G2	 Kit,	 requires	 only	 standard	 laboratory	 equipment,	 a	 simple,	 convenient	 and	
stable	storage	method	for		the	purpose	of	testing	sperm	DNA	fragmentation	would	
be	advantageous.	 	DNA	has	been	successfully	extracted	from	air‐dried	semen	and	
one	particular	study	has	investigated	the	use	of	air‐dried	semen	slides	as	a	method	
of	 storage	 prior	 to	 DNA	 fragmentation	 testing,	 however,	 the	 effects	 of	 time	 and	
temperature	on	the	integrity	of	spermatozoa	DNA	has	not	been	considered.			
	
The	 first	 objective	 of	 this	 present	 study	 was	 to	 investigate	 the	 relationship	
between	sperm	DNA	fragmentation	(using	the	Halosperm®	G2	Test	Kit)	and	semen	
analysis	 results	 (measured	 according	 to	 the	 4th	 and	 5th	 Edition	 WHO	 semen	
iv	
	
analysis	manuals)	 to	 determine	 the	 clinical	 utility	 of	 the	 Halosperm	 assay.	 	 The	
second	objective	was	to	consider	extrinsic	effects	on	the	DNA	integrity	of	air‐dried	
semen	in	order	to	develop	an	alternative	storage	method	for	semen	prior	to	DNA	
fragmentation	testing	using	the	Halosperm	assay.	
 
A	retrospective	analysis	was	carried	out	on	905	consecutive	semen	samples	with	
4th	 and	 5th	 Edition	 semen	 analysis	 and	 Halosperm	 result.	 Pearson	 correlations,	
analysis	by	ANOVA	and	post‐hoc	testing	by	Tukey’s	HSD	were	used	for	statistical	
analysis.	Multiple	aliquots	of	semen	samples	were	prepared	to	achieve	fresh,	snap	
frozen	and	air‐dried	samples.	Samples	were	sequentially	assessed	for	sperm	DNA	
fragmentation	using	 the	Halosperm®	G2	kit	 (Halotech	DNA	SL,	Spain)	and	scored	
against	 300	 sperm,	 with	 fragmentation	 results	 ≥30%	 considered	 positive.	
Fragmentation	 levels	 were	 compared	 between	 the	 different	 protocols.	 	 Multiple	
aliquots	 of	 semen	 samples	 were	 then	 air‐dried	 to	 test	 the	 fragmentation	 levels	
between	 different	 slide	 types,	 reconstituting	 fluids,	 times	 and	 temperatures.	
Pearson’s	 correlation	 coefficient	 and	 paired	 t‐tests	 were	 used	 for	 statistical	
analysis.		
	
In	 summary,	 whilst	 significant	 associations	 exist	 between	 sperm	 DNA	
fragmentation	 and	 sexual	 abstinence,	 volume	 of	 the	 ejaculate,	 sperm	
concentration,	 normal	 sperm	 morphology	 and	 sperm	 motility,	 the	 Halosperm	
assay	 may	 provide	 an	 explanation	 for	 infertility	 where	 semen	 analysis	 cannot.	
Furthermore,	 air‐drying	 semen	 is	 a	 simple	 and	 stable	 storage	method,	 for	 up	 to	
one	 month	 at	 ‐22	 degrees,	 prior	 to	 DNA	 fragmentation	 testing	 with	 the	
Halosperm®	G2	kit.	
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1	
	
1 Introduction 
Infertility,	 which	 is	 defined	 as	 the	 failure	 to	 conceive	 a	 child	 subsequent	 to	 12	
months	of	unprotected	intercourse	between	a	couple	of	reproductive	age	(Singh	&	
Agarwal,	2011),	is	recognised	by	the	World	Health	Organisation	(WHO)	as	a	public	
health	 concern	 (Boivin,	 Bunting,	 Collins,	 &	 Nygren,	 2007).	 	 Of	 all	 couples	
attempting	to	have	children,	between	17%	and	25%	will	be	diagnosed	as	infertile	
with	approximately	50%	of	these	cases	being	attributed	to	male	infertility	(Singh	&	
Agarwal,	2011;	Venkatesh	et	al.,	2011).		
	
Male	 infertility	 has	 traditionally	 been	 diagnosed	 on	 the	 basis	 of	 a	 number	 of	
standard	 parameters	 including	 seminal	 volume,	 pH,	 morphology,	 motility	 and	
concentration	as	recommended	by	the	WHO’s	laboratory	manual	which	focuses	on	
the	 examination	 of	 human	 semen	 (World	 Health	 Organisation,	 2010),	 	 hereafter	
referred	 to	 as	 the	 guidelines	 or	manual.	 Periodically,	 new	manuals	 are	 released;	
the	first	being	published	in	1980	with	updates	being	released	in	1987,	1992,	1999	
and	the	5th	Edition	in	2010	(Esteves,	Zini,	et	al.,	2012).	The	5th	Edition	guidelines	
radically	change	semen	analysis	interpretation	so	that	patients	diagnosed	with	an	
abnormal	semen	analysis	under	4th	Edition	guidelines	may	be	diagnosed	as	having	
a	normal	semen	analysis	using	5th	Edition	criteria.	The	reference	values	published	
prior	 to	 the	 5th	 Edition	 were	 derived	 from	 vague	 reference	 populations	 and	
consequently	 lack	 clarity,	 resulting	 in	 some	 confusion	 (Catanzariti,	 Cantoro,	
Lacetera,	 Muzzonigro,	 &	 Polito,	 2013;	 Cooper	 et	 al.,	 2010)	 which	 has	 been	
acknowledged	by	the	WHO	itself	(Esteves,	Zini,	et	al.,	2012;	Menkveld,	Holleboom,	
&	Rhemrev,	2011).	Despite	clearly	defined	reference	ranges	being	included	in	the	
5th	 Edition,	 debate	 has	 ensued	 over	 its	 legitimacy,	 with	 concerns	 being	 raised	
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regarding	the	basis	upon	which	these	reference	ranges	were	built	(Eliasson,	2010).	
Therefore	there	is	no	definitive	consensus	between	laboratories	on	which	edition	
(4th	or	5th)	should	be	used	(Lu,	Zhang,	Hu,	Huang,	&	Lu,	2010).		
	
However,	 regardless	 of	which	 reference	 values	 are	 used,	 routine	 semen	 analysis	
does	not	 consider	 sperm	DNA	 integrity	 and	 therefore,	whilst	 it	 plays	 an	 integral	
role	in	diagnosing	male	infertility	(De	Jonge,	2012),	it	has	its	limitations.	Research	
has	 shown	 that	 approximately	 15%	 of	 infertile	 men	 tested	 have	 semen	 with	
normal	semen	analysis	parameters	(Omran,	Bakhiet,	&	Dashti,	2013;	Schulte,	Ohl,	
Sigman,	&	Smith,	2010).	As	a	 result,	 there	has	been	considerable	 focus	on	sperm	
DNA	 fragmentation	 and	 its	 association	 with	 reproductive	 outcomes.	 	 Increased	
levels	 of	 DNA	 damage	 have	 been	 correlated	with	 infertile	men	 (Chohan,	 Griffin,	
Lafromboise,	De	Jonge,	&	Carrell,	2006;	Schulte	et	al.,	2010;	Shamsi,	Imam,	&	Dada,	
2011;	 Tamburrino	 et	 al.,	 2012;	 Yilmaz	 et	 al.,	 2010;	 Zini,	 2011),	 severe	 semen	
defects	 (Mangiarini	 et	 al.,	 2013;	 Sun,	 Jurisicova,	 &	 Casper,	 1997;	 Varshini	 et	 al.,	
2012),	poor	fertilisation	rates	(Bakos,	Thompson,	Feil,	&	Lane,	2007;	Lewis	et	al.,	
2013),	 increased	 risk	 of	 pregnancy	 loss	 after	 assisted	 reproductive	 technology	
(ART)	 (Lewis	 et	 al.,	 2013;	 Robinson	 et	 al.,	 2012;	 Zini,	 Boman,	 Belzile,	 &	 Ciampi,	
2008)	and	negative	results	in	both	ART	(Simon	et	al.,	2013)	and	natural	conception	
(Barratt	et	al.,	2010).	 	Consequently,	 tests	 focusing	on	sperm	DNA	 fragmentation	
(SDF)	measurement	have	been	proposed	to	be	a	valuable	adjunct	to	routine	semen	
analysis	when	attempting	to	evaluate	male	infertility	(Lewis	et	al.,	2013;	Schulte	et	
al.,	2010).				
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Since	 the	 first	 proposal	 more	 than	 thirty	 years	 ago	 that	 suggested	 changes	 in	
sperm	 chromatin	 structure	 may	 be	 associated	 with	 reduced	 fertility	 rates	
(Evenson,	Darzynkiewicz,	&	Melamed,	1980),	a	number	of	tests	to	measure	sperm	
DNA	integrity	have	been	developed;	the	sperm	chromatin	structure	assay	(SCSA),	
terminal	deoxynucleotidyl	transferase‐mediated	deoxyuridine	triphosphates	nick‐
end	 labelling	 (TUNEL),	 single	 cell	 gel	 electrophoresis	 (Comet)	 and	 sperm	
chromatin	dispersion	(SCD)	assays	(Chohan	et	al.,	2006).	 	Although	none	of	these	
assays	have	been	endorsed	by	the	WHO,	it	acknowledges	the	use	of	several	of	these	
for	 ”testing	 the	 regularity	 of	 sperm	 chromatin	 and	 DNA”	 (2010,	 p.	 157).		
Conversely,	 with	 such	 an	 array	 of	 tests	 available,	 it	 has	 become	 increasingly	
evident	 that	 the	 standardisation	 of	 tests	 and	 uniformity	 in	 terms	 of	 clinical	
interpretation	 are	 now	 required	 (Boe‐Hansen,	 Ersbøll,	 &	 Christensen,	 2005;	
Shamsi	et	al.,	2011).	 	Until	such	time	as	there	is	standardisation	in	the	execution,	
analysis	and	clinical	interpretation	of	DNA	fragmentation	assays	it	is	unlikely	that	
DNA	fragmentation	testing	will	be	formally	accepted	as	a	part	of	routine	diagnostic	
testing	in	andrology	laboratories	worldwide	(Fernández	et	al.,	2005).		
		
Factors	which	have	likely	prohibited	DNA	integrity	tests	from	being	standardised	
before	now	include	the	requirement	of	specialised	equipment	to	not	only	carry	out	
such	 tests	 (Boe‐Hansen	 et	 al.,	 2005)	 but	 also	 to	 store	 and	 transport	 samples	
(Aitken,	Allan,	 Irvine,	&	Macnamee,	1996;	Riel,	Yamauchi,	Huang,	Grove,	&	Ward,	
2011;	 Royster	 et	 al.,	 2000).	 	 The	 optimisation	 of	 methods	 used	 to	 assess	 DNA	
integrity	and	the	development	of	a	simplified	method	of	semen	storage	is	therefore	
particularly	significant	to	ART.	
	
4	
	
Whilst	 sperm	DNA	 integrity	can	be	assessed	 in	a	number	of	different	ways,	each	
has	 its	 benefits	 and	 limitations.	 	 In	 terms	 of	 simplicity,	 cost	 effectiveness	 and	
availability	 however,	 only	 the	 commercially	 available	 kits	 based	 on	 the	 sperm	
chromatin	dispersion	test	appear	to	fulfil	these	criteria.		Other	DNA	fragmentation	
assays	 require	 either	 specialised	 equipment,	 are	 labour	 intensive	 and/or	 are	
complex	(Chohan	et	al.,	2006).			
	
Current	methods	of	semen	storage	require	either	liquid	nitrogen	(LN2)	or	dry	ice	
entailing	 high	 costs	 or	 complicated	 logistical	 implications	 (Aitken	 et	 al.,	 1996;	
Dondero	et	al.,	2006;	Royster	et	al.,	2000)	and	hence	a	simplified	storage	method	
would	 be	 advantageous.	 	 In	 the	 forensic	 setting,	 DNA	 has	 been	 successfully	
extracted	 from	 air‐dried	 saliva	 (Walsh	 et	 al.,	 1992)	 and	 semen	 (Giusti,	 Baird,	
Pasquale,	 Balazs,	 &	 Glassberg,	 1986;	 McNally	 et	 al.,	 1989)	 and	 is	 routinely	
recovered	from	penile	and	vaginal	swabs	which	are	air‐dried	(Martin	et	al.,	2006).		
Additionally,	 Yap	 and	 Matson	 (2012)	 	 have	 shown	 that	 air‐dried	 semen	 can	 be	
successfully	 air‐dried	 onto	 a	 glass	 microscope	 slide,	 reconstituted	 with	 seminal	
plasma	 and	 then	 used	 to	 assess	 sperm	 DNA	 fragmentation	 levels	 using	 the	
Halosperm®	G2	Test	Kit.	
	
This	 present	 study	 aimed	 to	 formally	 investigate	 the	 clinical	 utility	 of	 the	
Halosperm®	 G2	 assay	 using	 both	 4th	 and	 5th	 Edition	 WHO	 Semen	 analysis	
guidelines	 and	 to	 evaluate	 alternative	methods	 for	 short‐term	 storage	 of	 human	
semen	 prior	 to	 testing	 DNA	 fragmentation	 with	 the	 Halosperm®	 G2	 Test	 Kit.			
Extrinsic	 factors	 such	 as	 the	 storage	 protocol,	 nature	 of	 reconstituting	 fluid	 and	
stability	over	time	and	temperature	were	also	considered.			
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2 Literature Review  
2.1 Human Infertility 
The	likelihood	of	a	healthy	couple	of	reproductive	age	having	unprotected	sexual	
intercourse	and	achieving	pregnancy	for	each	reproductive	cycle	is	approximately	
20	to	25%	with	increasing	probabilities	of	conception	over	time:	60%	in	the	first	6	
months,	84%	within	 the	 first	12	months	and	92%	in	the	 first	48	months	(Kamel,	
2010).	 	 Infertility	or	 subfertility	 is	diagnosed	 in	 a	 couple	who	have	not	 achieved	
conception	 after	 12	 months	 of	 unprotected	 regular	 sexual	 activity	 where	 the	
female	partner	is	under	35	years	of	age,	or	after	6	months	if	she	is	above	35	years	
of	age	(Kamel,	2010),	or	immediately	where	an	obvious	cause	is	evident	(Speroff,	
Glass,	&	Kase,	1999).	 	This	obvious	cause	being	shared	equally	between	men	and	
women	(Evenson,	Larson,	&	Jost,	2002).	There	are	two	different	types	of	infertility:	
Primary	 infertility	which	 is	 determined	when	 a	 couple	 has	 not	 previously	 had	 a	
live	birth	and	secondary	infertility	when	the	same	couple	has	had	at	least	one	live	
birth	previously	(Buy	&	Ghossain,	2013).		
	
A	number	of	different	factors	can	cause	infertility,	some	of	which	include:	defects	
relating	 to	genetics,	urogenital	and	reproductive	systems,	gametogenesis,	gamete	
function,	 fertilization	 and	 embryonic	 development	 (Matzuk	 &	 Lamb,	 2008).		
Additionally,	 lifestyle	factors	 	have	been	shown	to	affect	fertility	in	both	men	and	
women	 (Ferreira	 et	 al.,	 2010).	 In	 most	 world	 regions,	 infertility	 incidence	 was	
similar	 in	 2010	 to	 that	 in	 1990	 (Mascarenhas	 et	 al.,	 2013),	 however,	 reports	
suggesting	an	increase	in	male	subfertility	are	of	concern	(Sharpe	&	Irvine,	2004),	
particularly	 since	 there	 appears	 to	 be	 a	 common	 belief	 that	 subfertility	 has	
changed	since	the	WHO	introduced	lower	reference	ranges	when	analysing	human	
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semen	 (Barratt,	 Björndahl,	Menkveld,	&	Mortimer,	 2011).	 	 Notwithstanding	 this,	
dramatic	 advances	 have	 been	made	 in	ART	with	 the	 first	 baby	 to	 be	 born	 by	 in	
vitro	fertilization	in	1978,	followed	by	the	introduction	of	intracytoplasmic	sperm	
injection	 (ICSI)	 in	 1992.	 	 ICSI	 essentially	 circumvented	 male	 factor	 infertility	
(Varghese,	 du	 Plessis,	 &	 Agarwal,	 2008).	 	 Not	 surprisingly	 therefore,	 assisted	
reproductive	technology	(ART)	appears	to	be	increasing	with	4%	more	couples	per	
year	attempting	ART	(Lewis	et	al.,	2013).			
	
2.2 Male Infertility 
In	couples	of	reproductive	age	with	fertility	related	issues,	male	infertility	has	been	
found	to	be	responsible	for	50%	of	cases,	whether	directly	or	 indirectly	(Singh	&	
Agarwal,	 2011)	with	more	 than	half	 of	 these	 cases	being	 idiopathic	 (Poongothai,	
Gopenath,	&	Manonayaki,	 2009).	 	 Any	 aspect	 that	 disrupts	 the	 process	 of	 sperm	
production	 and/or	 its	 quality	has	 the	potential	 to	 cause	male	 infertility	with	 the	
major	causes	including	varicocoele,	cryptorchidism,	testicular	failure,	genital	tract	
obstruction,	 ejaculatory	 dysfunction,	 gonadotrophin	 exposure,	 hormone	
dysfunction,	infections,	genetic	conditions,	cancer	and	systemic	diseases	(Esteves,	
Miyaoka,	&	Agarwal,	2011).		
	
2.2.1 Human Semen 
Human	 semen	 is	 primarily	 composed	 of	 seminal	 fluid,	 secreted	 by	 a	 number	 of	
different	 accessory	 glands	 and	 spermatozoa	 which	 are	 produced	 in	 the	 testis	
(Johnson,	2013).	The	accessory	glands	comprise	the	seminal	vesicles,	prostate	and	
bulbourethral	 glands	which	 contribute	 approximately	 60%,	 30%	 and	 5%	 of	 the	
volume	 of	 seminal	 fluid	 respectively	 (Martini	 &	 Nath,	 2011).	 When	 ejaculated,	
these	 components	 are	 not	 entirely	mixed	 and	 the	 semen	 therefore	 is	 not	 a	 fully	
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homogenous	 fluid	 (Fleming	 &	 Cooke,	 2009).	 Within	 15	 to	 60	 minutes	 at	 room	
temperature	 after	 ejaculation	 however,	 semen	 will	 liquify,	 resulting	 in	 a	 more	
homogenous	liquid.	An	average	ejaculate	is	between	2ml	and	5ml	and	dependent	
on	 the	 concentration	 of	 spermatozoa,	 characteristically	 has	 a	 grey‐opalescent	
appearance	(World	Health	Organisation,	2010).	Human	semen	however	is	known	
to	vary	between	ejaculates	of	different	men	and	can	also	vary	between	ejaculates	
of	 the	 same	 man	 at	 different	 time	 points	 (Amann,	 2009;	 World	 Health	
Organisation,	2010).	From	a	biological	perspective,	such	variations	are	attributed	
to	many	different	factors	including	the	composition	of	semen,	the	source	of	these	
components	and	the	secretions	associated	with	them	(Björndahl,	2011).	
	
	Whilst	 the	 primary	 role	 of	 the	 spermatozoon	 is	 to	 deliver	 paternal	 genetic	
material	 to	 the	 oocyte	 at	 fertilisation	 (Ramalho‐Santos	 et	 al.,	 2007),	 the	 seminal	
fluid	 has	 no	 direct	 role	 in	 fertilisation,	 despite	 being	 a	 complex	 biological	 fluid	
composed	 of	 inorganic	 and	 organic	 constituents	 which	 allow	 it	 to	 fulfill	 several	
different	 functions	 (Rolland	 et	 al.,	 2012).	 The	 seminal	 fluid	 instead	 acts	 as	 a	
transport	medium	for	spermatozoa,	is	actively	involved	in	the	maturation	process	
of	 the	 spermatozoa,	 provides	 an	 energy	 source	 from	 fructose	 and	 due	 to	 its	
prostaglandin	 levels,	 protects	 the	 spermatozoa	 from	 the	 acidic	 nature	 of	 vaginal	
fluids	 (Fleming	 &	 Cooke,	 2009;	Mann,	 1964;	 Owen	 &	 Katz,	 2005;	 Rolland	 et	 al.,	
2012).		In	addition	to	these	functions,	antioxidant	enzymes	within	seminal	plasma	
have	been	shown	to	have	a	protective	role	against	 lipid	peroxidation	with	sperm	
chromatin	 being	 stabilised	 because	 of	 its	 zinc	 content	 (Rolland	 et	 al.,	 2012;	
Tavilani,	Goodarzi,	Vaisi‐raygani,	Salimi,	&	Hassanzadeh,	2008).	
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2.2.2 Mechanisms in Sperm Production and Ejaculation 
Under	normal	conditions,	 spermatozoa	are	produced	 in	 the	seminiferous	 tubules	
within	 the	 testes,	 transforming	 diploid	 spermatogonial	 germ	 cells	 into	 haploid	
spermatozoa	in	a	complex	biological	process	of	cellular	transformation	referred	to	
as	spermatogenesis	(Hess	&	de	Franca,	2008).	This	is	a	process	of	precisely	timed	
and	 extremely	 organised	 cycles	 whereby	 each	 stem	 cell	 first	 multiplies	 by	
continual	mitotic	divisions	 followed	by	meiosis	1	and	2	 in	half	 the	cells	resulting	
from	 these	 mitotic	 divisions.	 The	 remaining	 cells	 are	 used	 to	 renew	 their	 own	
population.		Meiosis	entails	chromosomal	duplication,	genetic	recombination	and	a	
reductional	 division	 to	 produce	 four	 haploid	 spermatids	 in	 a	 cycle	 which	 lasts	
around	 12	 days	 (Esteves	 et	 al.,	 2011).	 	 Spermatids	 will	 then	 differentiate	 into	
spermatozoa,	 via	 spermiogenesis	 (Hess	 &	 de	 Franca,	 2008).	 	 During	
spermiogenesis,	 the	 cell	 undergoes	 dramatic	 changes	 in	 terms	 of	 structure	 and	
function.	 The	majority	 of	 the	 cell’s	 cytoplasm	 is	 shed,	 the	 nucleus	 elongates,	 the	
acrosome	and	mid‐piece	are	 formed,	and	 the	chromatin	 is	 condensed	 (Marcon	&	
Boissonneault,	2004).	 	The	highly	condensed	spermatozoa	are	 then	released	 into	
the	lumen	of	the	seminiferous	tubules	prior	to	storage	in	the	epididymis	to	begin	
maturation	 until	 the	 time	 of	 ejaculation	 (Hess	 &	 de	 Franca,	 2008).	 The	
spermatozoa	 however,	 will	 only	 complete	 maturation	 within	 the	 female	
reproductive	tract	(Esteves	et	al.,	2011).	According	to	Mortimer	et	al.,	(2013)	this	
is	 not	 an	 efficient	 storage	 process	 as	 dependent	 on	 the	 individual,	 spermatozoa	
become	 moribund	 or	 die	 after	 a	 relatively	 short	 period.	 	 As	 a	 result,	 without	
ejaculation	 occurring	 every	 few	 days,	 spermatozoa	 in	 an	 ejaculate	 may	 well	 be	
compromised	(Mortimer	et	al.,	2013).	 	Under	sympathetic	stimulation,	ductal	and	
epididymal	muscles	contract	conducting	the	spermatozoa	to	the	prostatic	urethra.		
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Fluids	 secreted	 by	 the	male	 reproductive	 glands	 (seminal	 vesicles,	 prostate	 and	
bulbourethral)	are	combined	with	the	spermatozoa	to	 form	semen.	The	semen	is	
then	 expelled	 through	 the	 urethra	 under	 the	 influence	 of	 periurethral	 muscle	
contraction	 (Esteves	 et	 al.,	 2011).	 This	 process,	 from	 the	 beginning	 of	 sperm	
production	 to	 ejaculation	 is	 around	 60	 to	 70	 days	 (Misell	 et	 al.,	 2006).	 	 Male	
infertility	 may	 result	 from	 any	 interference	 in	 any	 step	 throughout	 the	 entire	
process	 from	 sperm	 production	 to	 ejaculation	 (Esteves,	 Hamada,	 Kondray,	
Pitchika,	&	Agarwal,	2012).		
	
2.2.3 Spermatozoon Anatomy 
Although	a	deceptively	simple	cell,	the	mature	spermatozoon	is	highly	specialized	
(Martini	 &	 Nath,	 2011)	 and	 plays	 a	 vital	 role	 in	 the	 continuance	 of	mammalian	
species	 with	 its	 primary	 purpose	 being	 to	 deliver	 an	 intact	 complement	 of	 the	
paternal	 haploid	 genome	 to	 the	 oocyte	 at	 fertilization	 (Ramalho‐Santos	 et	 al.,	
2007).	 	 Unlike	 somatic	 cells,	 mature	 spermatozoa	 lack	 intracellular	 structures	
permitting	 optimal	 size,	 mass	 and	 motility.	 	 Typical	 spermatozoa	 are	
approximately	 50µm	 in	 length	 and	 are	 organized	 into	 three	 distinctive	 regions	
known	as	the	head,	middle	piece	and	tail	(Martini	&	Nath,	2011).			
	
The	 majority	 of	 the	 mature	 spermatozoon	 head	 is	 taken	 up	 by	 a	 flattened	 and	
elongated	 nucleus	 (Martini	 &	 Nath,	 2011)	 which	 contains	 highly	 condensed	
chromatin	with	deoxyribonucleic	acid	(DNA)	being	arranged	in	a	specific	manner,	
quite	different	to	that	of	somatic	cells		(Ramalho‐Santos	et	al.,	2007;	Zini	&	Libman,	
2006).		The	DNA	in	spermatozoa	is	stabilised	by	protamines	which	counterbalance	
the	repulsion	of	phosphodiester	bonds	in	the	backbone	of	DNA	allowing	the	DNA	
to	fold	up	onto	itself	and	create	tightly	wound	toroids.		The	protamine	toroids	are	
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arranged	in	linear	arrays,	further	maximising	compaction.	A	small	percent	of	DNA	
is	bound	 to	histones,	however,	 the	majority	of	 these	are	 replaced	by	protamines	
during	 the	 maturation	 process	 to	 provide	 even	 tighter	 compaction	 (Singh	 &	
Agarwal,	 2011).	 As	 a	 result	 of	 this	 differentiation	 during	 spermatogenesis	 a	
predominantly	 protamine	 based	 DNA	 packaging	 arrangement	 is	 evident,	 as	
opposed	 to	 the	histone	packaging	 configuration	 in	 somatic	 cells	 (Balhorn,	2007).		
In	 the	 mature	 spermatozoon,	 approximately	 4%	 of	 the	 DNA	 is	 histone	 bound	
(Singh	&	Agarwal,	 2011).	 The	paternal	 genome	 therefore	 is	 somewhat	protected	
during	 the	transportation	 from	male	to	 female	reproductive	tracts	(Schulte	et	al.,	
2010)	 which	 eases	 the	 delivery	 and	 transference	 of	 genetic	 information	 to	 the	
oocyte	 (Miller,	 Brinkworth,	 &	 Iles,	 2010).	 	 DNA	 integrity	 of	 spermatozoa	 is	
however	vulnerable	to	a	number	of	environmental	and	lifestyle	factors	which	may	
result	 in	abnormal	chromatin	structures,	prior	 to	being	ejaculated	 from	the	male	
(Agarwal	&	Said,	2003).			
	
The	balance	of	the	mature	spermatozoon	is	made	up	of	the	middle	piece	containing	
condensed	 mitochondrial	 rods	 arranged	 around	 axial	 filaments	 which	 provide	
energy	 for	 the	 tail	 to	 “lash”	 providing	mobility	 to	 the	 spermatozoon	 (Martini	 &	
Nath,	2011).	
	
2.2.4 Damage to Sperm Genomic Material 
DNA	damage	 in	 spermatozoa	may	 range	 from	 chromosomal	 aberrations	 such	 as	
deletions	 and	 aneuploidies	 to	 epigenetic	 modifications	 and	 mutations	 to	 single	
and/or	double	 strand	DNA	breaks	which	 is	 commonly	 referred	 to	as	sperm	DNA	
fragmentation	 (SDF)	 (Sharma,	 Said,	 &	 Agarwal,	 2004).	 	 It	 is	 SDF	 which	 is	
considered	to	be	the	most	common	of	all	DNA	damage	in	spermatozoa	that	results	
11	
	
in	 abnormal	 transmission	 of	 paternal	 DNA	 (Tamburrino	 et	 al.,	 2012).	 Although	
much	research	has	focused	on	SDF	in	ejaculated	spermatozoa	(Chohan	et	al.,	2006;	
Evenson	 et	 al.,	 1999;	 Sakkas,	 1999;	 Simon	 et	 al.,	 2010;	 Smit,	 Romijn,	Wildhagen,	
Weber,	&	Dohle,	2010;	Venkatesh	et	al.,	2011)	and	various	mechanisms	have	been	
linked	with	 it,	 the	exact	source	and	nature	of	such	damage	remains	controversial	
(Sharma	et	al.,	2004).			
	
A	 number	 of	 mechanisms	 that	 have	 been	 suggested	 to	 explain	 the	 incidence	 of	
these	 anomalies	 in	 the	 human	 ejaculate	 include	 damage	 to	 chromatin	 packaging	
induced	 during	 the	 maturation	 process	 (Singh	 &	 Agarwal,	 2011;	 Twigg,	 Fulton,	
Gomez,	 Irvine,	 &	 Aitken,	 1998),	 oxidative	 stress	 and	 abortive	 apoptosis	 (Aitken,	
Jones,	&	Robertson,	2012;	Sharma	et	al.,	2004;	Singh	&	Agarwal,	2011).			
	
A	 disparity	 between	 antioxidant	 capacity	 and	 the	 production	 of	 reactive	 oxygen	
species	(ROS)	in	spermatozoa	causes	oxidative	stress	(Agarwal,	Saleh,	&	Bedaiwy,	
2003;	Paick,	2003)	and	practically	every	human	ejaculate	is	tainted	with	potential	
sources	 of	 ROS	which	 can	 cause	 chromosome	 deletions,	 chromatin	 cross‐linking	
and	 DNA	 base	 oxidation	 (Agarwal	 &	 Said,	 2005).	 	 Additionally,	 ROS	 plays	 an	
important	 role	 in	 mediating	 apoptosis	 which	 sequentially	 results	 in	 a	 high	
incidence	of	both	single	and	double	stranded	DNA	breaks	(Aitken	&	Baker,	2002).		
Since	spermatozoa	have	little	cytoplasm,	there	is	a	lack	of	cytoplasmic	antioxidants	
and	as	such	the	spermatozoon	 is	vulnerable	to	oxidative	stress	brought	about	by	
ROS.	 	 Furthermore,	 unsaturated	 fatty	 acids	 which	 attract	 unwarranted	 ROS	 are	
common	in	the	spermatozoon’s	plasma	membrane.		This	mechanism	brings	about	
oxidative	 stress	 resulting	 in	 degradation	 of	 the	 cell	 membrane	 and	 therefore	
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weakening	 the	 spermatozoon’s	 defence	 mechanisms	 (Singh	 &	 Agarwal,	 2011).		
Increased	 levels	 of	 ROS	 have	 also	 been	 correlated	 with	 reduced	 sperm	motility	
(Agarwal,	 Ikemoto,	 &	 Loughlin,	 1994;	 Armstrong	 et	 al.,	 1999;	 Lenzi,	 Lombardo,	
Gandini,	Alfano,	&	Dondero,	1993),	however	the	exact	mechanism	of	action	is	not	
fully	understood	(Makker,	Agarwal,	&	Sharma,	2009).		
	
Apoptosis	 is	 a	 key	mechanism	 to	 control	 the	 number	 of	 proliferating	 germ	 cells	
and	to	remove	old	or	defective	spermatids	and	spermatozoa	via	activation	of	Fas	
surface	 proteins	 and	 associated	 ligands	 (Agarwal	 &	 Said,	 2003).	 	 Inappropriate	
Fas‐ligand	 production	 may	 result	 in	 spermatozoa	 with	 damaged	 DNA	 avoiding	
apoptosis	and	being	integrated	into	the	gene	pool	(Singh	&	Agarwal,	2011).			
	
Owing	 to	 the	 intrinsic	 nature	 of	 chromatin	 compaction	 and	 organisation,	 strand	
breaks	 are	 a	 common	 form	of	DNA	damage	 in	 spermatozoa.	 	 The	 tension	on	 the	
phosphodiester	backbone	created	by	the	formation	of	toroids	can	only	be	released	
by	single	strand	breaks.	 	These	sporadic	breaks	allow	the	DNA	to	 further	 fold	on	
itself,	adding	to	increased	compaction.		Where	insufficient	mechanisms	are	in	place	
to	eliminate	such	cells,	(such	as	apoptosis)	spermatozoa	in	the	ejaculate	will	have	
increased	levels	of	DNA	fragmentation	(Singh	&	Agarwal,	2011).		
	
Many	external	environmental	 factors	have	also	been	shown	to	cause	SDF	such	as	
environmental	 toxicants	 (Evenson	 &	 Wixon,	 2005),	 heat	 stress	 (Pérez‐Crespo,	
Pintado,	&	Gutiérrez‐Adán,	2008;	Singh	&	Agarwal,	2011)	and	radiation	(Singh	&	
Agarwal,	 2011).	 	 Recreational	 drugs,	 cigarette	 smoke,	 certain	 medications	 and	
coffee	contain	chemicals	which	can	also	impact	on	the	DNA	in	spermatozoa,	either	
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by	 directly	 causing	 strand	 breaks	 or	 via	 oxidative	 methods	 (Singh	 &	 Agarwal,	
2011).		
	
None	 the	 less,	 fertile	 men	 have	 been	 shown	 to	 have	 some	 degree	 of	 SDF	 and	
infertile	men	 substantially	more	 SDF	 than	 their	 fertile	 counterparts	 (Fernández‐
Gonzalez	et	 al.,	 2008;	Tamburrino	et	 al.,	 2012;	Zini	&	Libman,	2006).	 	Hence	 the	
level	of	DNA	fragmentation	should	play	a	role	in	the	clinical	management	of	male	
infertility	(Evenson	&	Wixon,	2006).		
	
2.3 Diagnostic Role of Semen Analysis 
Semen	 analysis	 has	 long	 been	 regarded	 as	 the	 diagnostic	 cornerstone	 for	 male	
factor	 infertility	 (De	 Jonge,	 2012)	 and	 it	 is	 well	 documented	 that	 it	 should	 be	
carried	out	according	to	standardised	proceedures	(Barratt	et	al.,	2010;	Castilla	et	
al.,	 2006;	 Keel,	 2002).	 As	 such,	 more	 recent	 diagnosis	 has	 predominantly	 been	
based	on	routine	semen	analysis	as	described	by	the	WHO	laboratory	manual	4th	
(1999)	 and/or	 5th	 (2010)	 Editions.	 These	 guidelines	 outline	 standardised	
parameters	to	characterise	normal	spermatozoa	(Singh	&	Agarwal,	2011)	and	in	its	
most	 basic	 part	 describes	 the	 testicular	 function	 (De	 Jonge,	 2012)	with	 focus	on	
sperm	 concentration,	motility	 and	morphology	 (Cooper	 et	 al.,	 2010).	 Due	 to	 the	
guidelines	having	radically	changed	between	these	two	editions,	a	man	presenting	
with	an	abnormal	semen	analysis	under	4th	Edition	guidelines	may	be	considered	
to	have	a	normal	semen	analysis	when	tested	using	5th	Edition	guidelines.		
	
There	 are	differing	opinions	on	 the	 value	of	 the	5th	Edition	 (Barratt	 et	 al.,	 2011;	
Eliasson,	 2010;	 Jequier,	 2010;	 Lewis	 et	 al.,	 2013)	 and	 consequently	 not	 all	
laboratories	 have	 formally	 adopted	 the	 latest	 guidelines	 (Lu	 et	 al.,	 2010).	 One	
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particular	 concern	 over	 the	 WHO	 5th	 Edition	 reference	 values	 is	 due	 to	 the	
reference	population,	despite	this	being	significantly	better	than	previous	editions	
(Lewis	et	al.,	2013;	Penn	et	al.,	2011).	It	is	worth	noting,	that	the	European	Society	
of	 Human	 Reproduction	 and	 Embryology	 (ESHRE)	 basic	 semen	 analysis	 course	
material	is	produced	by	the	ESHRE	and	Nordic	Association	for	Andrology	(NAFA),	
the	standard	of	which	is	grounded	in	protocols	defined	by	the	WHO	and	Practical	
Laboratory	Andrology	 (Barratt	 et	 al.,	 2011;	Mortimer,	 1994).	 	 Previously	 ESHRE	
and	 NAFA	 standards	 have	 been	 updated	 in	 response	 to	 new	 findings,	 however	
recently	 they	 have	 specifically	 deviated	 from	 the	WHO	 5th	 Edition	 because	 they	
suggest	that	some	factors	are	scientifically	and	clinically	inappropriate	(Barratt	et	
al.,	2011).		
	
According	to	WHO	guidelines	a		semen	analysis	performed	on	an	infertile	man	may	
reveal	 a	 number	 of	 abnormal	 conditions	 ranging	 from	 oligozoospermia	 (low	
concentration),	 asthenozoospermia	 (reduced	 motility),	 teratozoospermia	 (poor	
morphology)	 or	 an	 amalgamation	 of	 each	 of	 these	 such	 as	
oligoasthenoteratozoospermia	(low	concentration	with	reduced	motility	and	poor	
morphology)	(Poongothai	et	al.,	2009).	 	Conversely,	 	 standard	semen	parameters	
can	 reveal	 a	 high	degree	of	 variability	 (Zini,	 2011)	 and	have	been	 considered	 as	
only	 a	 poor	 predictor	 of	 fertilising	 potential	 and	 a	 meagre	 predictor	 of	
reproductive	outcomes	(Guzick	et	al.,	2001).	Furthermore,	some	infertile	men	have	
been	 shown	 to	 have	 a	 normal	 semen	 analysis	 (Avendaño	 et	 al.,	 2009;	 French,	
Sabanegh	Jr.,	Goldfarb,	&	Desai,	2010).		
	
In	an	attempt	to	improve	male	infertility	diagnosis,	sperm	DNA	fragmentation	has	
become	one	of	 the	most	 researched	sperm	 factors	 in	 the	 last	decade	 (Agarwal	&	
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Said,	2011)	and	is	now	regarded	by	some	as	a	more	promising	test	(Barratt	et	al.,	
2010;	Evenson,	Kasperson,	&	Wixon,	2007;	Lewis	et	al.,	2013).		
	
2.4 Relevance of Sperm DNA Damage 
Whilst	 studies	 have	 shown	 that	 spermatozoa	 with	 compromised	 DNA	 are	
associated	with	reduced	fertilisation	rates	(Ji	et	al.,	2012),	longer	times	to	conceive	
and	 early	 pregnancy	 loss	 (Simon	 et	 al.,	 2013),	 advances	 in	 ART	 have	 allowed	
spermatozoa	 with	 an	 altered	 genome	 to	 fertilise	 oocytes	 in	 vitro	 (Lewis	 et	 al.,	
2013).	 	 Although	 oocytes	 can	 repair	 a	 certain	 amount	 of	 sperm	 DNA	 damage	
(Menezo,	Dale,	&	Cohen,	2010),	 residual	DNA	damage	 from	 the	male	gamete	can	
still	 be	 translated	 into	 chromosomal	 aberrations	 and	 gene	 mutations	 after	
fertilisation,	 amplifying	 the	 possibility	 	 of	 genetic	 diseases,	 cancer	 and	
developmental	 defects	 in	 the	 offspring	 (Aitken,	 Baker,	 &	 Sawyer,	 2003).	
Furthermore,	children	conceived	by	ICSI	have	a	higher	occurrence	of	disease	than	
those	 spontaneously	 conceived	 (Basatemur	&	 Sutcliffe,	 2008;	Katari	 et	 al.,	 2009)	
with	 literature	 showing	 a	 link	 between	 the	 higher	 occurrence	 and	 the	 father’s	
sperm	 (Aitken,	 De	 Iuliis,	 &	McLachlan,	 2009).	 	 Therefore,	 quantifying	 SDF	 levels	
not	only	provides	a	guide	for	ART	treatment	(Sharma	et	al.,	2004)	but	also	protects	
the	integrity	of	future	generations.	
	
2.5 Evaluation of Sperm Nuclear DNA Integrity 
A	number	of	different	methods	 to	assess	sperm	DNA	damage	have	been	devised,	
however,	the	SCSA,	TUNEL,	and	Comet	are	recognised	as	the	most	commonly	used	
(Sharma	 et	 al.,	 2004;	 Venkatesh	 et	 al.,	 2011).	 	 The	 SCD	 assay	 although	 being	 a	
relatively	new	technique	(Chohan	et	al.,	2006)	appears	to	have	gained	popularity	
due	 to	 its	 simplicity,	 cost	effectiveness	 (Absalan	et	al.,	2012),	 reproducibility	and	
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the	fact	that	its	results	are	highly	correlated	with	the	SCSA	(Fernández	et	al.,	2005).		
Despite	technical	differences	between	each	of	these	assays,	they	all	fundamentally	
detect	damaged	DNA	in	spermatozoa	(Dugum,	Sandlow,	&	Brannigan,	2011).		It	is	
important	 however	 to	 consider	 not	 only	 the	 strengths	 and	 weaknesses	 of	 each	
assay,	 but	 also	 how	 well	 they	 correlate	 with	 each	 other	 when	 considering	 how	
DNA	fragmentation	testing	can	be	standardised.	
	
2.5.1 Sperm Chromatin Structure Assay (SCSA) 
SCSA	 is	 based	 on	 the	 principle	 that	 sperm	 DNA	 is	 susceptible	 to	 low	 pH.		
Spermatozoa	are	therefore	subjected	to	an	acid	treatment	to	denature	the	DNA	and	
then	 stained	 using	 a	metachromatic	 dye	 named	 acridine	 orange	 (Evenson	 et	 al.,	
1980).	 	 	 Using	 flow	 cytometry,	 fluorescence	 signals	 are	 then	measured	whereby	
denatured	 single	 stranded	 DNA	 will	 emit	 a	 red	 signal	 whilst	 intact	 and	 double	
stranded	DNA	breaks	will	emit	a	green	signal.		Quantifying	the	metachromatic	shift	
from	green	to	red	fluorescence	provides	the	extent	of	DNA	denaturation	(Agarwal	
&	 Said,	 2003)	 which	 is	 commonly	 referred	 to	 as	 the	 DNA	 fragmentation	 index	
(DFI);	 the	higher	the	DFI	value,	 the	higher	the	percent	of	cells	with	DNA	damage	
(Evenson	et	al.,	2002).		Semen	samples	with	a	DFI	of	>30%	using	this	method	are	
associated	with	 a	 reduced	 level	 of	 pregnancy	 success	 (Evenson	&	Wixon,	 2006).		
Whilst	the	SCSA	has	been	clinically	validated	for	statistical	robustness	(Shamsi	et	
al.,	2011),	according	to	some	experts	in	the	field,	the	equipment	requirements	of	a	
flow	cytometer	and	its	associated	software	and	technical	expertise	are	its	foremost	
limitations	 (Fernández	 et	 al.,	 2005;	 Shamsi	 et	 al.,	 2011)	 and	 which	 for	 some	
andrology	 laboratories	 remains	 unattainable	 due	 to	 cost	 factors	 (Chohan	 et	 al.,	
2006).			
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2.5.2 Terminal Deoxynucleotidyl Transferase dUTP Nick End 
Labeling (TUNEL) 
The	 TUNEL	 assay	 is	 based	 on	 the	 principle	 of	 attaching	 a	 labelled	 nucleotide,	
deoxyuridine	triphosphate	(dUTP)	to	the	3’	OH	end	of	single	and	double	stranded	
DNA	 breaks	 by	 means	 of	 the	 template‐independent	 enzyme	 terminal	
deoxynucleotidyl	 transferase	 (TdT).	 	 The	 incorporated	 dUTP	 is	 labelled	 with	 a	
fluorescent	 tag	which	 produces	 a	 signal	 allowing	 the	 breaks	 to	 be	measured	 by	
flow	 cytometry,	 fluorescent	 microscopy	 or	 bright	 field	 microscopy	 (Gorczyca,	
Gong,	 &	 Darzynkiewicz,	 1993;	 Shamsi	 et	 al.,	 2011).	 	 The	 strength	 of	 the	 signal	
illustrates	 the	 number	 of	 strand	 breaks;	 spermatozoon	 heads	 with	 highly	
fragmented	 DNA	 will	 emit	 a	 bright	 fluorescent	 light	 whilst	 sperm	 with	 normal	
chromatin	 integrity	 produce	 only	 background	 fluorescence	 (Hekmatdoost,	
Lakpour,	&	Sadeghi,	2009).	
	
The	most	recognised		limitation	to	this	assay	is	that	the	TdT	is	unlikely	to	access	all	
3’OH	ends	due	 to	 the	highly	 compacted	nature	of	 sperm	chromatin	 (Mitchell,	De	
Luliis,	 &	 Aitken,	 2011)	 and	 because	 there	 is	 no	 lysis	 of	 the	 spermatozoon	
membrane,	the	chromatin	remains	highly	compacted	(Tesarik,	Mendoza‐Tesarik,	&	
Mendoza,	 2006).	 Zini	 and	 Sigman	 (2009)	 advocate	 that	 whilst	 fluorescent	
microscopy	or	flow	cytometry	are	not	necessary,	a	consequence	of	having	variable	
assay	protocols	is	that	thresholds	are	not	standardised.		
	
2.5.3 Single Cell Gel Electrophoresis Assay (Comet) 
The	 Comet	 assay	 involves	 staining	 spermatozoa	with	 a	 fluorescent	 DNA‐binding	
dye	(Fluorochrome),	suspending	these	in	an	agarose	gel	and	then	subjecting	them	
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to	electrophoresis.		The	fragmented	DNA	will	migrate	during	electrophoresis,	with	
shorter	 fragments	 or	 low‐molecular	weight	DNA	moving	 further	 through	 the	 gel	
toward	 the	 positive	 anode	 than	 high‐molecular	 weight	 intact	 DNA.	 	 Sperm	with	
fragmented	DNA	will	therefore	display	a	comet	tail	characteristic	(Klaude,	1996).		
Using	 imaging	 software,	 the	 comet	 tail	 is	 measured	 by	 length	 and	 fluorescence	
intensity	to	determine	the	level	of	DNA	fragmentation	(Schulte	et	al.,	2010).		Whilst	
the	main	advantage	of	the	Comet	assay	is	that	it	is	a	direct	method	that	quantifies	
both	 single	 and	 double	 stranded	 breaks	 (Agarwal	 &	 Said,	 2003),	 according	 to	
Shamsi	et	al.,	(2011),	the	labour	intensity	of	this	assay	is	a	major	limitation.		
	
2.5.4 Sperm Chromatin Dispersion (SCD) 
	The	 SCD	 assay	 determines	 the	 vulnerability	 of	 sperm	DNA	 to	 acid	 denaturation	
and	 follows	 the	 principle	 that	 induced	 condensation	 is	 directly	 related	 to	 sperm	
DNA	fragmentation	(Muriel	et	al.,	2006).		Sperm	are	suspended	in	an	agarose	micro	
gel	before	being	placed	on	an	agarose	pre‐treated	slide	which	renders	the	sperm	in	
a	“suspension‐like	environment”	on	the	slide	(Fernández	et	al.,	2005,	p.	834).	 	An	
acid	solution	is	applied	to	the	agarose/sperm	matrix	to	denature	the	DNA	followed	
by	 treatment	 with	 a	 lysis	 buffer	 to	 lyse	 cell	 membranes	 and	 remove	 nuclear	
proteins.	 	 As	 a	 result	 a	 halo	 of	 dispersed	 DNA	 loops	 surround	 the	 central	 core	
which	can	be	viewed	under	bright	 field	microscopy	after	staining	 the	slides	with	
Wright’s	stain.	Sperm	with	intact	DNA	will	show	as	having	large	halos	whilst	those	
with	elevated	DNA	fragmentation	will	generate	no	halo	or	at	the	most	a	very	small	
halo	(Fernández	et	al.,	2005).		
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The	 most	 commonly	 cited	 advantages	 of	 the	 Halosperm®	 G2	 assay	 (which	 is	
modelled	on	 the	SCD	assay)	 include	 the	 relatively	 short	and	simple	protocol,	 the	
requisite	 of	 only	 standard	 laboratory	 equipment	 and	 its	 cost	 effectiveness	
(Fernández	 et	 al.,	 2005;	 Shamsi	 et	 al.,	 2011).	 The	 only	 limitation	 identified	 by	
Chohan	et	al.,	with	this	assay,	is	inter‐observer	subjectivity	(Chohan	et	al.,	2006).	
	
Chohan	and	colleagues	(2006)	have	shown	a	significant	correlation	(r>0.866	and	
P<0.001)	 for	 sperm	 DNA	 fragmentation	 on	 the	 same	 samples	 between	 SCSA,	
TUNEL	 and	 SCD.	 	 In	 contrast	 however	 Sharma	 and	 colleagues	 (2004)	 claim	 a	
significant	 correlation	 between	 the	 SCSA,	 Comet	 and	 TUNEL	 assays	 but	 do	 not	
provide	any	statistical	evidence,	nor	do	they	comment	on	the	SCD	assay.	
	
2.6  Clinical Utility of the Halosperm® G2 kit  
The	ultimate	sperm	function	test	or	series	of	tests	should	determine	the	reason	for	
male	factor	 infertility,	predict	the	pregnancy	rate	and	guide	the	clinician	towards	
the	 therapeutic	 route	 which	 would	 alleviate	 the	 dysfunction	 (Franken	 &	
Oehninger,	 2012).	 	 Whilst	 a	 standard	 semen	 analysis	 may	 assist	 a	 clinician	 in	
selecting	 the	 treatment	 approach	 for	 some	 infertile	 couples,	 repeatedly	 normal	
results	 in	 other	 couples	 may	 go	 unexplained,	 providing	 the	 clinician	 with	 little	
direction	(Saleh	et	al.,	2002).	A	number	of	studies	have	been	undertaken	to	assess	
the	relationship	of	specific	semen	analysis	factors	and	DNA	fragmentation	such	as	
motility	(Peluso	et	al.,	2013),	morphology	(Franken	&	Oehninger,	2012;	Mangiarini	
et	 al.,	 2013),	 motility	 and	 morphology	 (Avendaño	 et	 al.,	 2009;	 Avendaño	 &	
Oehninger,	 2011;	 Irvine	 et	 al.,	 2000;	 Lopes,	 Sun,	 Jurisicova,	 Meriano,	 &	 Casper,	
1998;	Tandara	et	al.,	2013)	with	none	having	considered	all	semen	analysis	factors	
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in	the	same	study	(volume,	concentration,	motility	and	morphology)	 	and	several	
having	 used	 alternative	 DNA	 fragmentation	 assays	 to	 the	 Halosperm	 assay	
(Avendaño	 et	 al.,	 2009;	 Avendaño	 &	 Oehninger,	 2011;	 Lopes	 et	 al.,	 1998;	
Mangiarini	et	al.,	2013;	Saleh	et	al.,	2002).		Furthermore,	no	study	has	considered	
the	association	of	DFL	(DNA	fragmentation	level)	to	semen	quality	as	classified	by	
both	 the	 WHO	 4th	 and	 5th	 Edition	 semen	 analysis	 guidelines.	 Catanzariti	 and	
colleagues	 (2013)	 have	 assessed	 the	 difference	 in	 semen	 quality	 (considering	
count,	motility	and	morphology)		using	both	these	editions,	however	they	did	not	
compare	 this	 to	 DNA	 fragmentation	 levels.	 	 Due	 to	 the	 debate	 surrounding	 the	
WHO	 4th	 and	 5th	 Editions	 and	 the	 fact	 that	 the	WHO	 laboratory	manual	 for	 the	
examination	and	processing	of	human	semen	has	long	been	regarded	as	the	‘gold	
standard’	(Walczak‐Jedrzejowska	et	al.,	2013)	plus	the	WHO	4th	Edition	guidelines	
are	predominantly	followed	in	the	laboratory	where	this	research	was	carried	out,	
the	 inclusion	 of	 both	 editions	 are	 warranted	 when	 comparing	 DFLs	 to	 WHO	
reference	 ranges.	 	 This	 comparison	 will	 provide	 some	 insight	 into	 the	 clinical	
utility	of	the	Halosperm	assay.	
	
One	particular	study	that	has	assessed	concentration,	motility	and	morphology	in	
relationship	 to	 DNA	 fragmentation	 levels	 used	 the	 SCSA	 method	 and	 only	
considered	 the	 WHO	 4th	 Edition	 guidelines	 when	 determining	 the	 normality	 of	
semen	analysis	parameters	(Saleh	et	al.,	2002).	The	results	of	this	study	indicated	
that	 poor	 semen	 quality	 (based	 on	 4th	 Edition	 guidelines)	 was	 associated	 with	
increased	DFL.	Using	the	TUNEL	assay,	Avendaño		and	colleagues	(2009)	reported	
that	morphologically	normal	and	highly	motile	spermatozoa	(as	categorised	by	the	
WHO	4th	Edition	guidelines)	may	have	DNA	fragmentation	and	infertile	men	with	
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severe	teratozoospermia	had	significantly	higher	DNA	fragmentation	levels.		Based	
on	WHO	5th	 Edition	 guidelines,	 using	 the	 TUNEL	 assay,	Mangiarini	 et	 al.,	 (2013)	
also	concluded	that	teratozoospermic	samples	had	a	significantly	higher	incidence	
of	DNA	fragmentation	than	normozoospermic	samples.	Using	the	Halosperm	assay,	
Peluso	 and	 colleagues	 (Peluso	 et	 al.,	 2013)	 showed	 a	 significant	 correlation	
between	 percentage	 spermatozoa	motility	 (based	 on	 4th	 Edition	 guidelines)	 and	
the	 DFL,	 as	 did	 Tandara	 et	 al,.	 (2013).	 	 Interestingly,	 	 Catanzariti	 et	 al.,	 (2013)	
concluded	that	the	5th	Edition	guidelines	did	not	change	the	final	verdict	of	semen	
analysis	from	the	4th	Edition	guidelines		since	concordance	was	very	high	when	all	
three	 parameters	 (concentration,	 motility	 and	 morphology)	 were	 considered	
together	and	when	each	parameter	was	analysed	on	its’	own.	
	
2.7 Storage of Human Semen 
Although	the	protocols	of	semen	storage	in	LN2	have	advanced	substantially	since	
Jahnel’s	first	report	in	1938	of	successful	long	term	storage	of	human	spermatozoa	
(Macpherson,	 1960),	 the	 use	 of	 LN2	 remains	 a	 costly	 process	 which	 entails	
complicated	 logistical	 and	 technical	 implications	 (Aitken	et	 al.,	 1996;	Dondero	et	
al.,	 2006;	 Royster	 et	 al.,	 2000).	 	 Whilst	 LN2	 may	 be	 mandatory	 in	 cases	 where	
spermatozoa	 must	 be	 preserved	 for	 subsequent	 insemination,	 e.g.	 donor	 sperm	
insemination,	 prior	 to	 cancer	 therapy	 and	 where	 the	 male	 partner	 spends	 long	
periods	of	time	away	from	his	female	partner	(Boe‐Hansen	et	al.,	2005),	alternative	
methods	 of	 storage	 are	 possible	 where	 only	 the	 DNA	 must	 be	 preserved	
(Imoedemhe,	Holiva,	&	Adam,	2004).			
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2.7.1 Alternative Methods of Storage  
A	study	conducted	by	 Imoedemhe	and	colleagues	 (2003)	demonstrated	 that	 it	 is	
possible	to	achieve	successful	fertilization	of	human	oocytes	via	intra‐cytoplasmic	
sperm	injection	with	sperm	that	had	been	air‐dried	and	stored	for	 four	weeks	at	
21oC	or	8oC.		Following	these	observations,	they	continued	their	research	to	assess	
the	 long	 term	 storage	 of	 air‐dried	 sperm	 to	 determine	 its	 effects	 on	 the	
morphology	of	the	spermatozoa	and	reported	no	evidence	of	deterioration	in	air‐
dried	 spermatozoa	 which	 was	 stored	 at	 0oC	 for	 ten	 months	 and	 at	 8oC	 for	 six	
months	 before	 being	 resuspended	 in	 Earle’s	 medium	 (Imoedemhe	 et	 al.,	 2004).	
Whilst	 this	 study	has	 provided	 valuable	 information	 concerning	 air‐dried	 semen	
samples,	the	DNA	integrity	following	these	storage	conditions	was	not	considered.		
Furthermore,	the	study	size	was	a	limiting	factor	as	only	ten	semen	samples	were	
analysed	(Imoedemhe	et	al.,	2004).		
	 	 	
In	the	forensic	setting,	DNA	has	been	successfully	extracted	from	air‐dried	semen	
(Giusti	et	al.,	1986;	Martin	et	al.,	2006;	McNally	et	al.,	1989)	and	is	often	recovered	
from	 penile	 and	 vaginal	 swabs	which	 are	 typically	 exposed	 to	 air	 (Martin	 et	 al.,	
2006).	 	 Additionally,	 Robbins	 and	 colleagues	 (1993)	 have	 effectively	 performed	
fluorescence	 in	 situ	 hybridisation	 on	 air‐dried	 semen	 microscope	 slides.	 	 Such	
evidence	suggests	that	sperm	DNA	remains	unchanged	when	semen	is	air‐dried.	
	
A	preliminary	study	by	Yap	and	Matson	(2012)		ascertained	that	human	semen	can	
be	air‐dried	on	 flat	microscope	slides	 for	short	 term	storage	prior	 to	sperm	DNA	
fragmentation	 testing	 using	 the	 Halosperm	 G2	 kit.	 The	 research	 compared	 DNA	
fragmentation	results	in	snap	frozen/thawed	semen	samples	in	LN2	with	air‐dried	
semen	samples	from	the	same	men	and	reported	a	significant	correlation	(r=0.982,	
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p=0.000).		Moreover,	they	advocated	that	further	analysis	was	required,	including	
the	effects	of	time	and	temperature	on	air‐dried	semen	and	the	use	of	alternative	
reconstituting	 fluids	 to	 further	 refine	 this	 technique.	 	 Consequently,	 this	 present	
study	aimed	to	formally	evaluate	air‐dried	semen	(with	particular	consideration	of	
the	 storage	 protocol,	 nature	 of	 reconstituting	 fluid,	 slide	 type	 and	 stability	 over	
time	and	temperature)	as	an	alternative	storage	method	for	semen	prior	to	testing	
DNA	fragmentation	levels	with	the	Halosperm	G2	kit.	
	
Whilst	 Yap	 and	Matson	 did	 not	 report	 any	 difficulties	 associated	with	 using	 flat	
microscope	slides		(2012),	the	preliminary	stages	of	this	study	revealed	that	where	
semen	was	air‐dried	on	flat	slides,	 in	some	samples	the	semen	pool	became	flaky	
around	the	edges.	 	Since	concave	slides	have	been	used	in	other	settings	for	 long	
term	culture	(Thomas	et	al.,	2001),	it	was	hypothesised	that	concave	slides	would	
be	beneficial	for	this	study,	and	may	prevent	the	semen	from	thinning	at	the	edges,	
therefore	 avoiding	 potential	 flaking	 of	 the	 semen	 pool.	 	 Furthermore	 the	 semen	
pool	would	 be	 confined	 by	 the	well	 of	 the	 concave	 slide	 ensuring	 a	 consistently	
sized	pool	across	all	slides.				
2.8 Reconstitution Media 
In	order	to	liquefy	a	dried	semen	sample,	a	reconstitution	medium	is	required	so	
that	 the	 spermatozoa	 are	 resuspended	 and	 can	 be	 removed	 from	 a	 variety	 of	
sources	 (Giusti	 et	 al.,	 1986).	 	 Both	 phosphate	 buffered	 saline	 (PBS)	 and	 seminal	
plasma	are	 regularly	used	 in	 andrology	 laboratories	and	have	each	been	used	 in	
previous	 studies	 involving	 air‐dried	 semen	 (Martin	 et	 al.,	 2006;	 Yap	 &	 Matson,	
2012).		
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2.8.1 Seminal Plasma 
After	 centrifuging	 a	 semen	 sample	 and	 removing	 the	 pellet,	 seminal	 plasma	 is	
obtained.	 	 This	 has	 previously	 been	 used	 as	 a	 reconstituting	 medium	 prior	 to	
testing	the	DNA	integrity	of	air‐dried	semen	(Yap	&	Matson,	2012;	Yap	et	al.,	2012).		
Prior	to	DNA	integrity	testing	of	the	air‐dried	semen	samples,	each	air‐dried	semen	
slide	was	gently	mixed	with	40	µl	of	seminal	plasma	(which	had	previously	been	
centrifuged	 and	 stored	 at	 4oC)	 to	 resuspend	 the	 dried	 spot	 and	 then	placed	 in	 a	
0.5ml	conical	tube	(Eppendorf,	Germany).		Whilst	seminal	plasma	was	shown	to	be	
an	 effective	 reconstituting	 medium	 (Yap	 &	 Matson,	 2012),	 the	 nature	 of	 its	
composition	and	variability	(Milardi	et	al.,	2012)	prompted	this	writer	to	consider	
using	 phosphate	 buffered	 saline	 as	 a	 reconstituting	 medium.	 Furthermore,	 in	
addition	to	organ	specific	proteins,	the	origin	and	function	of	other	proteins	found	
in	seminal	plasma	remain	poorly	understood	(Milardi	et	al.,	2012).	Since	the	whole	
semen	 sample	was	 air‐dried,	 the	 use	 of	 seminal	 plasma	 as	 a	 reconstituting	 fluid	
would	mean	 the	 reconstituted	 air‐dried	 samples	 would	 contain	 double	 strength	
seminal	plasma.				
	
2.8.2 Phosphate Buffered Saline and Bovine Serum Albumin 
Forensic	laboratories	are	commonly	required	to	recover	spermatozoa	from	vaginal	
swabs	or	items	of	clothing	to	determine	if	sexual	intercourse	has	taken	place	in	an	
alleged	sexual	assault	case.	 	Furthermore,	to	determine	the	identity	of	the	alleged	
attacker,	 the	 extraction	 of	 spermatozoa	 must	 not	 affect	 the	 subsequent	 DNA	
profiling	(Martin	et	al.,	2006).		A	number	of	different	methods	are	used	to	recover	
spermatozoa	 prior	 to	 applying	 these	 to	 a	 microscope	 slide	 for	 assessment,	
however	 PBS	 has	 been	 shown	 to	 be	 an	 effective	 reconstituting	 fluid	 for	 this	
purpose	 (Giusti	 et	 al.,	 1986;	 Martin	 et	 al.,	 2006).	 	 PBS	 is	 a	 non‐toxic,	 neutral	
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solution	readily	used	in	most	biological	 laboratories	which	allows	cells	to	remain	
in	 their	 current	 state.	 	 The	 protocol	 used	 by	 Giusti	 and	 colleagues	 (Giusti	 et	 al.,	
1986)	required	that	fabric	containing	dried	semen	was	scrubbed	with	30ml	of	PBS	
(136mM	 sodium	 chloride,	 8mM	 sodium	 phosphate,	 dibasic,	 17mM	 sodium	
phosphate,	monobasic,	pH7.0).	 	After	24	hours	of	mild	agitation	 in	100ml	of	PBS	
(containing	 2%	 Sodium	 lauryl	 sarcosinate	(Sarkosyl®)	 at	 4oC,	 the	 solution	 was	
pressed	through	nylon	mesh	and	centrifuged	for	10	minutes	at	3600	rmp		at	4oC.		
After	resuspending	the	pellet	 in	1ml	of	PBS,	 the	sperm	count	of	each	sample	was	
conducted	 before	 isolating	 DNA.	 	 The	 successful	 extraction	 of	 DNA	 from	 dried	
semen	samples	on	fabric	using	PBS	as	a	reconstituting	medium	has	prompted	the	
hypothesis	that	PBS	may	be	a	potential	medium	for	reconstituting	air‐dried	semen	
on	 microscope	 slides.	 Since	 Sarkosyl®  is	 an	 ionic	 detergent	 which	 disrupts	
biological	membranes	(Garvin,	Bottinelli,	Gola,	Conti,	&	Soldati,	2009),	allowing	for	
DNA	 extraction	 (Griffin,	 2013),	 the	 addition	 of	 this	 solution	 was	 foreseen	 to	 be	
detrimental	 prior	 to	 DNA	 fragmentation	 testing	 as	 the	 Halosperm	 assay	 has	 its	
own	lysing	solution.			
	
Bovine	serum	albumin	(BSA)	 is	used	with	many	 laboratory	 techniques	due	 to	 its	
stability,	 lack	 of	 intrusion	within	 biological	 reactions	 (Farell	 &	 Alexandre,	 2012)	
and	 the	 fact	 that	 it	prevents	adhesion	 to	glass	surfaces	(Harrison,	Dott,	&	Foster,	
1982;	 Namasivayam,	 Robin,	 Bharani,	 Vigneshwaraprakash,	 &	 Vivek,	 2013).	 	 BSA	
has	also	been	shown	to	have	a	favourable	effect	when	amplifying	ancient	DNA	and	
that	which	has	been	found	in	fresh	and	marine	water	as	well	as	in	faeces	(Tarrand,	
Krieg,	&	Döbereiner,	1978;	Woide,	Zink,	&	Thalhammer,	2010).		For	these	reasons,	
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it	was	postulated	that	the	addition	of	BSA	to	PBS,	as	opposed	to	Sarkosyl®,	would	
be	advantageous.		
	
3 Summary and Theoretical Framework 
The	methods	used	to	assess	human	semen	as	described	in	the	WHO	4th	(1999)	or	
5th	(2010)	Edition	manuals		are	widely	used	in	fertility	laboratories	as	a	standard	
reference	to	begin	evaluating	male	factor	infertility	(Sánchez,	Wistuba,	&	Mallidis,	
2013).	 	 Since	 consensus	 over	 which	 edition	 should	 be	 used	 has	 not	 been	
established	as	yet,	some	laboratories	are	using	the	4th	Edition,	whilst	others	refer	
to	the	5th	Edition	(Eliasson,	2010;	Esteves,	Zini,	et	al.,	2012).	Despite	the	exclusion	
of	 DNA	 integrity	 testing	 in	 WHO	 recommendations	 to	 evaluate	 male	 factor	
infertility	(World	Health	Organisation,	2010)	many	studies	have	reported	that	DNA	
integrity	testing	is	a	valuable	diagnostic	tool	for	assessing	male	infertility	(Lewis	et	
al.,	 2013)	 and	 as	 such	 numerous	 laboratories	 have	 included	 sperm	 DNA	
fragmentation	analysis	as	an	adjunct	to	the	traditional	semen	analysis.	Few	studies	
have	considered	the	clinical	significance	of	semen	analysis	and	its	relationship	to	
DNA	fragmentation	levels,	whilst	none	have	measured	this	against	both	the	4th	and	
5th	Edition	WHO	semen	analysis	guidelines.		
	
Given	 the	 increasing	 focus	 on	 male	 factor	 infertility	 and	 the	 role	 that	 DNA	
fragmentation	 plays,	 it	 is	 important	 to	 develop	 strategies	 that	 provide	 a	 storage	
medium	 that	 allows	 for	 the	 analysis	 of	 DNA	 integrity	 in	 semen	 samples	 to	 be	
standardised,	more	efficient	and	provide	a	potential	platform	for	both	internal	and	
external	 quality	 assurance.	 	 Whilst	 other	 studies	 have	 evaluated	 the	 use	 of	 air‐
dried	semen,	only	one	study	(Yap	&	Matson,	2012)	has	considered	this	as	a	method	
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of	 semen	 storage	 prior	 to	 DNA	 fragmentation	 testing,	 however,	 the	 extrinsic	
factors	 associated	with	 such	 storage	methods	were	 not	 analysed.	 	 Consequently,	
this	 research	 project	 evaluated	 the	 relationship	 of	 semen	 analysis	 as	 measured	
using	the	WHO	4th	and	5th	Edition	semen	analysis	manuals	to	DNA	fragmentation	
levels	and	then	considered	the	extrinsic	factors	associated	with	air‐dried	semen.	
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4 Research Questions and Hypotheses 
4.1 Research Question 1 
What	are	the	relationships	between	semen	quality	according	to	 the	WHO	4th	and	
5th	Editions	and	sperm	DNA	fragmentation	levels	as	detected	with	the	Halosperm	
G2®	kit?	
	
4.1.1  Hypothesis 
It	 was	 expected	 that	 the	 proportion	 of	 semen	 samples	 which	 score	 above	 the	
recommended	DNA	fragmentation	level	will	shift,	dependent	on	whether	they	are	
compared	with	the	WHO	4th	or	5th	Edition	semen	quality	parameters.		
	
4.2 Research Question 2 
Can	a	solution	of	phosphate	buffered	saline	and	bovine	serum	albumin	be	used	as	a	
reconstituting	 fluid	 instead	 of	 seminal	 plasma	without	 any	 detrimental	 effect	 on	
the	DNA	integrity	of	air‐dried	semen?	
	
4.2.1  Hypothesis 
A	 simple	medium	 (e.g.	 phosphate	 buffered	 saline	 and	 bovine	 serum	 albumin)	 is	
equally	as	effective	as	seminal	plasma	to	reconstitute	air‐dried	semen.	
	
4.3 Research Question 3 
What	(if	 any)	 is	 the	difference	 in	DNA	 fragmentation	 levels	between	snap	 frozen	
and	fresh	samples	when	performing	the	Halosperm®	G2	test?	
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4.3.1  Hypothesis 
Current	 storage	 protocols	 prior	 to	 DNA	 fragmentation	 testing	 using	 the	
Halosperm®	G2	test	include	snap	freezing	in	liquid	nitrogen.		It	was	expected	that	
there	would	be	no	difference	 in	DNA	 fragmentation	 levels	when	comparing	snap	
frozen	and	fresh	samples.	
	
4.4 Research question 4 
How	 stable	 are	 air‐dried	 slides	 over	 time	 and	 at	 different	 temperatures	 prior	 to	
DNA	fragmentation	analysis	using	the	Halosperm®	G2	Test	Kit?	
	
4.4.1  Hypothesis  
After	consideration	of	 the	 literature,	 it	was	envisaged	 that	air‐dried	slides	would	
be	stable	at	4oC.	
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Figure 1: Experimental protocols 
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5 Materials and Methods 
Figure	1	shows	a	diagrammatic	representation	of	the	experimental	protocols	used	
in	 this	 study.	 	Part	1	 illustrates	 the	protocols	used	to	establish	 the	materials	and	
methods	 to	 be	 used	 in	 part	 2	 of	 the	 project.	 	 In	 summary	 a	 semen	 analysis	was	
conducted	on	all	samples	and	the	DNA	fragmentation	level	established	for	each	of	
these.	 	Seminal	plasma	and	a	solution	of	PBS	together	with	BSA	(PBS+BSA)	were	
the	 two	different	 types	of	 reconstituting	 fluids	 that	were	compared.	 	The	 type	of	
slide	 to	 be	 used	 for	 part	 2	 of	 the	 project	 was	 determined	 by	 comparing	 DNA	
fragmentation	 levels	 on	 flat	 and	 concave	 slides.	 	 PBS+BSA	 (as	 the	 reconstituting	
fluid)	 and	 concave	 slides	 (as	 the	 slide	 type)	 were	 used	 in	 part	 2	 of	 the	 project	
where	DNA	fragmentation	levels	were	compared	using	different	testing	protocols,	
followed	by	a	range	of	temperatures	over	different	periods	of	time.	
	
5.1 Ethics Approval 
Ethics	 approval	 was	 granted	 by	 Joondalup	 Health	 Campus	 Human	 Ethics	
Committee	 under	 reference	 number	 1222	 and	 the	 Human	 Research	 Ethics	
Committee	of	Edith	Cowan	University	under	reference	number	9147.		
	
5.2 Sample Collection 
The	semen	that	was	analysed	for	this	research	project	was	collected	from	patients	
attending	 Fertility	 North,	 Suite	 213,	 Specialist	 Medical	 Centre,	 Joondalup	 Health	
Campus.	The	participants	 in	 the	 study	were	men	aged	between	18	 and	64	years	
undergoing	semen	analysis	and	DNA	fragmentation	testing	as	part	of	their	fertility	
investigations	 at	 Fertility	 North.	 	 All	 participants	 included	 in	 this	 study	 were	
provided	with	an	information	letter	explaining	the	details	of	the	study	and	signed	a	
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strip.	For	sperm	motility	assessment,	a	wet	mount	approximately	20m	deep	was	
examined	with	a	phase	contrast	microscope	after	the	sample	had	stopped	drifting.		
The	motility	 of	 all	 spermatozoa	within	 the	 field	 of	 a	 defined	 area	were	 assessed	
and	 scored	 as	progressive,	 non‐progressively	motile	 or	 non‐motile.	 Spermatozoa	
were	 considered	 progressively	 motile	 where	 they	 actively	 moved,	 regardless	 of	
their	speed	in	either	a	linear	or	large	circular	pattern.	All	other	patterns	of	motility,	
where	there	was	no	progression,	were	considered	non‐progressively	motile.	 	The	
absence	of	any	movement	rendered	the	spermatozoa	non‐motile.		Sperm	numbers	
for	 each	 ejaculate	 were	 determined	 using	 a	 Neubauer	 Haemocytometer	 with	 a	
single	 count	 of	 200	 spermatozoa	 per	 replicate.	 	 This	 varies	 from	 the	 WHO	 5th	
Edition	 guidelines	 which	 suggest	 that	 several	 counts	 of	 200	 spermatozoa	 will	
reduce	 sampling	 error	 (World	 Health	 Organisation,	 2010).	 	 A	 single	 count	 was	
used	as	this	follows	the	Fertility	North	laboratory	protocol	which	is	predominantly	
based	 on	 the	 WHO	 4th	 Edition	 guidelines.	 To	 identify	 the	 percentage	 of	
morphologically	normal	spermatozoa	in	an	ejaculate	a	drop	of	semen	was	placed	
onto	 a	 labelled	 microscope	 slide	 and	 then	 smeared	 by	 dragging	 a	 22	 x	 22mm	
coverslip	over	the	drop	before	 it	was	allowed	to	dry.	 	The	slide	was	then	stained	
using	“Diff	Quick”	solutions	(Bacto	Laboratories	Pty	Ltd,	Mt	Pritchard,	NSW	2170)	
as	per	the	manufacturer’s	instructions	and	200	consecutive	spermatozoa	counted.		
A	morphologically	normal	spermatozoon	has	an	oval	head	with	40%	to	70%	being	
covered	by	the	acrosome.		No	abnormalities	should	be	seen	in	the	neck,	midpiece	
or	tail	(World	Health	Organisation,	1999).		
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Semen	 parameters	 were	 then	 classified	 as	 normal	 or	 abnormal	 using	 the	 WHO	
laboratory	manuals	 for	examining	human	sperm	4th	and	5th	Editions	as	shown	in	
Table	1.			
Table 1: Cut off values for semen parameters according to WHO 4th Edition and 
WHO 5th Edition semen analysis criteria.  
(Adapted	from	Esteves	and	Agarwal,	2011)	
Semen	Parameters	 WHO	4th Edition WHO	5th Edition1	
Volume	(mL)	 2 1.5
Sperm	Concentration	(106/mL)		 20		 15
Motility	 50%	(a +	b)		 32%	(a	+	b)	
Morphology	(%	normal)	 14 4
	
Semen	 samples	 that	 scored	 below	 the	 recommended	 levels	 for	 each	 of	 the	
following	parameters	were	classified	as	follows:	
1.		 Sperm	concentration:	Oligozoospermia	(O)	
2.		 Sperm	concentration	and	morphology:	Oligoteratozoospermia	(OT)	
3.	 Sperm	 concentration	 and	 progressive	 motility:	 Oligoasthenozoospermia	
	 (OA)	
4.		 Sperm	 concentration,	 progressive	 motility	 and	 morphology:	
	 Oligoasthenoteratozoospermia	(OAT)	
	
Semen	 samples	 that	 scored	 above	 or	 equal	 to	 the	 sperm	 concentration	
recommended	values,	but	below	the	recommended	levels	for	each	of	the	following	
parameters	were	classified	as	follows:	
1.		 Morphology:	Normoteratozoospermia	(NT)	
2.	 Progressive	motility:	Normoasthenozoospermia	(NA)	
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3.		 Progressive	 motility	 and	 morphology:	 Normoasthenoteratozoospermia	
	 (NAT)	
	
Semen	 samples	 that	 scored	 above	 or	 equal	 to	 all	 parameters	 were	 classified	 as	
Normozoospermia	(N).	
	
5.3.2 DNA Fragmentation Analysis 
The	second	part	of	determining	the	clinical	utility	of	the	Halosperm	assay	(Figure	
2),	 required	 snap	 frozen	 samples	 (refer	 chapter	 5.5.2)	 to	 be	 analysed	 and	 their	
DNA	 fragmentation	 results	 compared	 with	 the	 semen	 analysis.	 Analysis	 was	
carried	out	using	 the	reagents	supplied	 in	 the	Halosperm®	G2	Test	Kit	 (Halotech	
DNA	 SL,	 Spain)	 plus	 additional	 reagents	 which	 included	 ethanol	 (95%),	
microscope	 slides	 and	 cover	 slips,	 distilled	 water	 and	 a	 water	 bath	 (37oC).	 The	
protocol	 for	 the	 Halosperm®	G2	 Assay	was	 used	 according	 to	 Appendix	 II.	 The	
low‐melting‐point	agarose	gel	supplied	with	the	kit	was	placed	in	a	water	bath	at	
90o‐100oC	 for	5	minutes	 to	melt	before	50L	was	 transferred	 into	 an	Eppendorf	
tube	at	37oC	for	5	minutes	to	permit	temperature	equilibration.		25L	of	the	semen	
sample	 was	 then	 added	 to	 the	 50L	 of	 liquefied	 and	 temperature	 equalised	
agarose	gel	and	mixed	until	fully	incorporated.		8L	of	the	semen‐agarose	mix	was	
pipetted	 onto	 a	 Halosperm®	 pre‐treated	 slide,	 covered	 with	 a	 22mm	 by	 22mm	
coverslip	and	placed	on	a	pre‐cooled	metal	 tray	 inside	a	refrigerator	at	4oC	 for	5	
minutes	to	enable	the	spermatozoa	to	become	embedded	in	the	agarose	gel.	 	The	
slide	was	then	placed	in	a	horizontal	position	on	top	of	a	petri	dish	inside	a	glass	
container	 before	 the	 coverslip	 was	 gently	 removed	 and	 an	 acid	 denaturation	
solution	(solution	1)	applied	for	7	minutes	and	then	drained.		This	was	followed	by	
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5.4 Quality Control of DNA Fragmentation Scoring  
To	assess	the	degree	of	variability	in	DNA	fragmentation	levels	in	the	same	sample	
when	 run	 in	 different	 batches	 using	 the	 Halosperm	 kit,	 low	 and	 high	 DNA	
fragmentation	level	quality	control	samples	were	assessed.	 	Two	batches,	each	of	
34	 positive	 and	 34	 negative	 samples	were	 processed	with	 the	 Halosperm	 assay	
over	68	different	batch	assays.	
	
Positive	quality	control	samples	were	made	from	pooled	semen	which	was	placed	
in	a	water	bath	at	90o	to	100oC	for	2	hours.			Negative	quality	control	samples	were	
made	 from	 pooled	 semen	 known	 to	 have	DNA	 fragmentation	 levels	 below	 30%.	
This	 semen	 was	 aspirated	 into	 orange	 (positive	 control)	 and	 green	 (negative	
control)	 labelled	 0.5ml	 IMV	 AI	 straws	 (Genetics	 Australia,	 Bacchus	 Marsh,	
Australia)	before	heat	sealing.	
	
The	 straws	 were	 then	 placed	 in	 a	 freezer	 (–22	 °C)	 for	 30	 minutes,	 then	 into	 a	
mixture	of	LN2	vapour	and	air	 in	 the	neck	of	a	LN2	container	 for	10–15	minutes.	
The	 frozen	 straws	 were	 then	 placed	 in	 plastic	 storage	 tubes	 and	 inserted	 into	
larger	 storage	 goblets	 in	 a	 LN2	 dewar.	 Prior	 to	 DNA	 fragmentation	 testing,	 the	
straws	were	 removed	 from	the	LN2	and	placed	on	a	workbench	 in	a	polystyrene	
tray	 to	 thaw	 at	 room	 temperature	 for	 between	 30	 and	 60	minutes.	 	Whilst	 the	
actual	 temperature	 of	 the	 laboratory	 was	 not	 monitored	 for	 this	 purpose,	 the	
expected	temperature	would	have	been	approximately	25oC	as	this	is	the	Fertility	
North	laboratory	protocol.	
	
To	consider	 if	 there	was	any	variability	when	the	same	sample	was	 tested	 in	the	
same	Halosperm	 run,	 34	 samples	were	 tested	 twice	 in	 the	 same	Halosperm	 run	
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and	the	DNA	fragmentation	levels	compared	by	the	same	technician	using	a	blind	
counting	technique.	
	
In	 evaluating	 the	 level	 of	 inter	 operator	 scoring,	 164	 Halosperm	 slides	 were	
analysed	 by	 2	 different	 operators	 using	 a	 blind	 count.	 	 The	 variability	 of	 DNA	
fragmentation	levels	reported	from	each	technician	was	compared.	
	
5.5 Processing Protocols  
5.5.1 Freshly Ejaculated Semen 
After	 liquefaction,	 freshly	 ejaculated	 semen	 samples	 (in	 the	 original	 container)	
were	 placed	 on	 bench	 coat	 for	 a	 maximum	 of	 35	 minutes	 before	 running	 the	
Halosperm	assay.		This	time	frame	allowed	for	a	portion	of	the	same	semen	sample	
to	 either	 be	 snap	 frozen	 and	 thawed	 (refer	 5.5.2	 below)	 or	 air‐dried	 and	
reconstituted	(refer	5.5.3,	5.5.5	and	5.5.5.2	below)	so	that	the	same	sample	could	
be	tested	in	the	same	Halosperm	run.	 	
	
5.5.2 Snap Frozen/Thawed Semen 
1.5ml	of	 liquefied	semen	was	placed	 into	a	1.8ml	Cryotube™	vial	which	was	then	
immediately	 plunged	 into	 LN2	 for	 snap	 freezing	 and	 stored	 until	 further	
processing.		Prior	to	further	processing,	the	Cryotube™	vial	was	removed	from	the	
LN2	and	placed	on	a	work	bench	in	a	polystyrene	tray	to	thaw	at	room	temperature	
for	between	30	to	60	minutes.		The	lid	of	the	Cryotube™	vial	was	loosened	to	allow	
trapped	LN2	to	escape	to	prevent	explosion	and	then	tightened	until	thawed.		
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5.5.3 Air-dried Semen  
Air	 dried	 slides	were	made	by	dispensing	50µl	 of	 thawed	 and/or	 fresh	 liquefied	
semen	onto	a	microscope	slide	and	immediately	placed	on	a	37°C	warming	stage	
(Minitüb	GmbH,	Germany)	for	between	25	and	30	minutes.		After	25	minutes,	the	
semen	pool	was	assessed	and	where	the	centre	of	the	semen	pool	was	translucent,	
the	slide	remained	on	the	warming	stage	for	a	further	5	minutes.		This	allowed	for	
the	 semen	 pool	 to	 be	 completely	 dry	 before	 the	 slide	 was	 removed	 from	 the	
warming	 stage.	 	 The	 air‐dried	 slide	 was	 placed	 on	 bench	 coat	 for	 2	 minutes	 to	
allow	 the	 slide	 to	 return	 to	 room	 temperature,	 before	 being	 placed	 in	 a	 sealed	
plastic	container	for	storage	or	further	processing.		
	
5.5.4 Storage of Air-dried Slides 
The	 air‐dried	 slides	 that	 were	 stored	 at	 room	 temperature	 were	 placed	 in	 an	
enclosed	wooden	slide	box	in	Fertility	North’s	Andrology	laboratory	until	 further	
processing.		Those	air‐dried	slides	that	were	stored	at	approximately	4oC	or	‐22oC	
were	placed	in	a	sealed	plastic	container	before	being	placed	in	a	fridge	or	freezer	
respectively	(Fisher	and	PaykelTM)	at	Fertility	North’s	Andrology	 laboratory	until	
further	 processing.	 	 The	 temperatures	 of	 both	 the	 fridge	 and	 freezer	 are	 tested	
daily	and	no	temperature	fluctuations	were	found	during	the	project,	however	as	
both	 applicances	 are	 of	 the	 frost	 free	 variety,	 it	 is	 possible	 that	 there	may	 have	
been	some	fluctuation	in	temperature	between	the	daily	recordings.	
	
5.5.5 Reconstitution of Air-dried Slides 
Immediately	 prior	 to	 assessing	 the	 sperm	 DNA	 fragmentation	 of	 an	 air‐dried	
semen	 sample,	 50µL	 of	 a	 specific	 reconstituting	 fluid	 was	 applied	 to	 the	 dried	
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semen.		This	was	gently	mixed	until	the	dried	semen	was	free	from	the	glass	slide	
and	the	solution	appeared	homogenous.		The	solution	of	semen	and	reconstituting	
fluid	was	then	placed	into	a	0.5ml	conical	tube	(Eppendorf,	Germany)	 for	further	
analysis.	
	
5.5.5.1 Seminal Plasma 
Seminal	plasma	was	obtained	by	centrifuging	the	semen	sample	at	16,000	rpm	for	
15	minutes	followed	by	removal	of	the	seminal	supernatant	without	disturbing	the	
pellet.	 	 An	 additional	 centrifugation	 of	 16,000	 rpm	 for	 a	 further	 10	 minutes	
preceded	the	final	removal	of	seminal	plasma	(again	without	disturbing	the	pellet)	
before	its	placement	in	a	Cryotube™	vial	and	storage	at	4oC.	
	
5.5.5.2 Phosphate Buffered Saline (PBS) and Bovine Serum 
Albumin (BSA) Solution 
The	 preparation	 of	 phosphate	 buffered	 saline	 is	 described	 by	 Sambrook,	 Fritsch	
and	Maniatis	(1989)	and	is	briefly	described	as	follows:		
The	following	was	added	to	800ml	of	distilled	water:	
8g	of	NaCl		
0.2g	of	KCl		
1.44g	of	Na2HPO4	
0.24g	of	KH2PO4	
Using	HCl,	adjust	the	pH	to	7.4	
Distilled	water	was	added	to	bring	the	total	volume	to	1	litre.	
This	solution	was	 then	dispensed	 into	10ml	conical	 tubes	and	0.3g	of	BSA	added	
before	storage.		Following	the	addition	of	BSA,	the	PBS+BSA	solution	was	stored	at	
4oC	for	a	maximum	of	10	days.	
	5.6 Fac
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glass	 microscope	 slide	 and	 the	 other	 a	 glass	 microscope	 slide	 with	 a	 concave	
middle	section)	were	prepared	as	described	in	chapter	5.5.2,	using	thawed	semen.		
A	total	of	16	slides	were	stored	for	one	day	at	4oC	using	the	methods	outlined	 in	
chapter	5.5.4	and	then	reconstituted	with	the	PBS+BSA	solution	using	the	method	
stated	 in	 chapter	5.5.5.2.	 	DNA	 fragmentation	 levels	 for	 each	 slide	 type	 from	 the	
same	sample	were	 compared	using	 the	Halosperm	assay	as	discussed	 in	 chapter	
5.4.	
	
To	assess	the	effect	of	slide	type,	when	stored	at	4oC	for	7	days,	10	samples	were	
used	 to	make	 up	 2	 air‐dried	 slides	 using	 the	 different	 slide	 types	 (a	 total	 of	 20	
slides).	 Again	 slides	 were	 reconstituted	 with	 PBS+BSA	 before	 running	 the	
Halosperm	 assay.	 DNA	 fragmentation	 levels	 for	 each	 slide	 type	 from	 the	 same	
sample	were	then	compared.			
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described	 in	 chapter	 5.5.5.2	 and	 DNA	 fragmentation	 levels	 measured	 using	 the	
Halosperm	assay.	 The	DNA	 fragmentation	 levels	 for	 air‐dried	 slides	 stored	 for	 1	
day	were	compared	against	the	same	sample	whose	air‐dried	slide	was	stored	for	
7	days.	
	
5.6.4.2 4oC: 1 Day versus 7 Days 
To	determine	if	the	processing	protocols	had	any	effect	on	the	DNA	fragmentation	
levels	 of	 air‐dried	 semen	 (Figure	 6),	 the	 DNA	 fragmentation	 levels	 from	 snap	
frozen	 and	 air‐dried	 samples	 stored	 at	 40C	 for	 1	 day	were	 compared	with	 those	
processed	in	the	same	manner	but	stored	for	7	days.	From	each	of	15	samples,	2	
aliquots	 of	 semen	 (total	 30	 aliquots)	 were	 prepared	 using	 the	 protocol	 as	
described	 in	 5.5.2.	 From	 each	 aliquot,	 one	 air‐dried	 slide	 was	 made	 using	 the	
protocol	 as	 described	 in	 chapter	 5.5.3.	 One	 slide	 from	 each	 semen	 sample	 was	
stored	 for	 one	 day	 and	 the	 other	 stored	 for	 7	 days	 at	 4oC	 using	 the	 protocol	 as	
described	 in	 chapter	 5.5.4.	 	 On	 the	 8th	 day	 each	 of	 the	 air‐dried	 slides	 was	
reconstituted	 using	 the	 protocol	 as	 described	 in	 chapter	 5.5.5.2	 and	 DNA	
fragmentation	levels	measured	using	the	Halosperm	assay.	The	DNA	fragmentation	
levels	for	air‐dried	slides	stored	for	1	day	were	compared	against	the	same	sample	
whose	air‐dried	slide	was	stored	for	7	days.	
	
5.6.4.3 4oC: 1 Day versus 30 Days  
To	determine	if	the	processing	protocols	had	any	effect	on	the	DNA	fragmentation	
levels	 of	 air‐dried	 semen	 (Figure	 6),	 the	 DNA	 fragmentation	 levels	 from	 snap	
frozen	 and	 air‐dried	 samples	 stored	 at	 40C	 for	 1	 day	were	 compared	with	 those	
processed	in	the	same	manner	but	stored	for	30	days.	From	each	of	10	samples,	2	
46	
	
aliquots	 of	 semen	 (total	 20	 aliquots)	 were	 prepared	 using	 the	 protocol	 as	
described	in	chapter	5.5.2.	From	each	aliquot,	one	air‐dried	slide	was	made	using	
the	protocol	as	described	in	chapter	5.5.3.	One	slide	from	each	semen	sample	was	
stored	for	one	day	and	the	other	stored	for	30	days	at	4oC	in	the	same	manner	as	in	
chapter	 5.5.4.	 	 On	 the	 31st	 day	 each	 of	 the	 air‐dried	 slides	was	 reconstituted	 as	
described	 in	 chapter	 5.5.5.2	 and	 DNA	 fragmentation	 levels	 measured	 using	 the	
Halosperm	 assay.	 The	DNA	 fragmentation	 levels	 for	 air‐dried	 slides	 stored	 for	 1	
day	were	compared	against	the	same	sample	whose	air‐dried	slide	was	stored	for	
30	days.	
	
5.6.4.4 -22oC: 1 Day versus 30 Days 
To	determine	if	the	processing	protocols	had	any	effect	on	the	DNA	fragmentation	
levels	 of	 air‐dried	 semen	 (Figure	 6),	 the	 DNA	 fragmentation	 levels	 from	 snap	
frozen	and	air‐dried	samples	stored	at	‐220C	for	1	day	were	compared	with	those	
processed	in	the	same	manner	but	stored	for	30	days.	From	each	of	11	samples,	2	
aliquots	 of	 semen	 (total	 22	 aliquots)	 were	 prepared	 using	 the	 protocol	 as	
described	in	chapter	5.5.2.	From	each	aliquot,	one	air‐dried	slide	was	made	using	
the	protocol	as	described	in	chapter	5.5.3.	One	slide	from	each	semen	sample	was	
stored	 for	 one	 day	 and	 the	 other	 stored	 for	 30	 days	 at	 ‐22oC	 as	 described	 in	
chapter	5.5.4.		On	the	31st	day	each	of	the	air‐dried	slides	was	reconstituted	in	the	
same	manner	as	in	chapter	5.5.5.2	and	DNA	fragmentation	levels	measured	using	
the	Halosperm	assay.	The	DNA	fragmentation	levels	for	air‐dried	slides	stored	for	
1	day	were	 compared	against	 the	 same	sample	whose	air‐dried	 slide	was	 stored	
for	30	days.	
	
47	
	
5.6.4.5 Air-dried Semen Stored over Time at -22oC 
To	determine	if	the	processing	protocols	had	any	effect	on	the	DNA	fragmentation	
levels	of	air‐dried	semen	(Figure	6),	the	DNA	fragmentation	from	snap	frozen	and	
air‐dried	 samples	 stored	 at	 ‐220C	were	measured	 over	 a	 period	 of	 time.	 From	 a	
single	semen	sample	known	to	have	a	low	DFI,	eight	air‐dried	slides	were	prepared	
from	a	 frozen‐thawed	sample	 (as	described	 in	chapter	5.5.2,	 followed	by	 the	air‐
drying	protocol	described	in	chapter	5.5.3).		Each	slide	was	individually	placed	into	
a	 sealed	 plastic	 container	 and	 stored	 at	 ‐22	 oC.	 	 These	 samples	 were	 used	 as	
negative	quality	controls	during	routine	clinical	Halosperm	tests.		On	the	day	of	a	
clinical	Halosperm	run,	one	slide	was	removed	from	the	 freezer,	reconstituted	as	
described	 in	 chapter	 5.5.5.2	 and	 included	 in	 the	 Halosperm	 assay	 as	 a	 negative	
quality	control	sample.	All	eight	samples	were	reconstituted	and	used	as	negative	
quality	 control	 samples	 in	 consecutive	 clinical	 analyses.	 	 From	a	different	 semen	
sample,	also	known	to	have	a	low	DFI,	six	air‐dried	slides	were	prepared	and	used	
as	negative	quality	 control	 samples	 in	 the	 following	consecutive	clinical	analysis.		
Protocols	as	discussed	in	chapters	5.5.2,	5.5.3	and	5.5.5.2	were	again	followed.	
	
From	a	single	semen	sample	known	to	have	a	high	DFI,	eight	air‐dried	slides	were	
prepared	from	a	frozen‐thawed	sample	(as	described	in	chapter	5.5.2,	followed	by	
air‐drying	protocol	described	in	chapter	5.5.3).		Each	slide	was	individually	placed	
into	a	sealed	plastic	container	and	stored	at	 ‐22	oC.	 	These	samples	were	used	as	
positive	quality	controls	during	routine	clinical	Halosperm	tests.	 	On	the	day	of	a	
clinical	Halosperm	run,	one	slide	was	removed	from	the	 freezer,	reconstituted	as	
described	 in	 chapter	 5.5.5.2	 and	 included	 in	 the	 Halosperm	 assay	 as	 a	 positive	
quality	control	sample.	All	eight	samples	were	reconstituted	and	used	as	positive	
quality	 control	 samples	 in	 consecutive	 clinical	 analyses.	 	 From	a	different	 semen	
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sample,	also	known	to	have	a	high	DFI,	six	air‐dried	slides	were	prepared	and	used	
as	 positive	quality	 control	 samples	 in	 the	 following	 consecutive	 clinical	 analysis.		
Protocols	as	discussed	in	chapters	5.5.2,	5.5.3	and	5.5.5.2	were	again	followed.	
	
5.7  Statistical Analysis  
To	 examine	 the	 relationship	 between	 sperm	 DNA	 fragmentation	 and	 semen	
analysis	 results,	 Pearson	 correlations	 and	 analysis	 by	 ANOVA	 were	 performed	
using	 StatistiXL	 (Nedlands,	Western	 Australia),	 with	 post‐hoc	 testing	 by	 Tukey’s	
HSD.	 	Proportions	were	compared	by	Chi‐squared	test	and	P<0.05	was	set	as	the	
minimum	 level	 of	 significance.	 	 To	measure	 the	 variation	 of	 results	 within	 each	
batch	and	confirm	the	quality	assurance	of	scoring	between	batches,	the	coefficient	
of	 variation	 was	 calculated	 (standard	 deviation	 x	 100/mean)	 and	 a	 precision	
profile	 built.	 The	 within	 run	 and	 between	 operator	 variability	 in	 scoring	 was	
analysed	using	repeated	measures	analysis	of	variation	(ANOVA),	difference	plots	
and	Student’s	t‐tests.		Similarly,	the	DNA	fragmentation	levels	for	each	of	the	above	
processing	 protocols	 (chapter	 5.6)	 were	 statistically	 analysed	 using	 Student’s	 t‐
tests	to	compare	the	different	experimental	regimes.		Confidence	intervals	were	set	
at	 0.05	 and	 significance	 levels	 are	 reported	 as	 p<0.05,	 p<	 0.01,	 p<0.001	 or	
p<0.0001.	 	All	 statistical	 analyses	were	performed	using	 the	Microsoft	 Excel	 and	
StatistiXL	(Nedlands,	Western	Australia)	statistical	packages.		 	
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6 Results 
6.1 Quality Control and Assay Precision 
The	mean	DNA	fragmentation	levels	±	the	standard	error	of	the	mean	(SEM)	of	the	
first	batch	of	low	and	high	controls	were	reported	as	10.5±0.55%	and	81.3±2.01%	
respectively.	 	 The	 fragmentation	 levels	 of	 the	 second	 batch	 of	 controls	 were	
20.7±0.82%	and	56.6±1.80%	for	the	low	and	high	controls	respectively	(Figure	7).		
	
Figure 7: Comparing DNA fragmentation results to determine consistency of 
results between Halosperm runs.  
Precision profile of 2 batches of controls each with one low and one high known DNA 
fragmentation level.  Values for each batch are the mean per group (n=34).  
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Using	 a	 repeated	 measures	 ANOVA,	 the	 variance	 of	 DNA	 fragmentation	 levels	
between	 subjects	 is	 significantly	 different,	 but	 no	 significant	 variance	 is	 seen	
between	different	measurements	of	the	same	individual	(Table	2).	The	mean	DNA	
fragmentation	percentage	±	SEM	for	two	replicates	of	the	same	semen	sample	was	
27.81±2.67	and	26.79±2.78	for	replicates	1	and	2	respectively.		Student’s	paired	t‐
test	between	the	two	replicates	was	t=1.84;	p=0.08.		The	Bland‐Altman	plot	(Figure	
8)	shows	the	DNA	fragmentation	difference	between	the	two	replicates.			
Table 2: Repeated Measures ANOVA showing variance among subjects differs 
significantly from the variance between measures of the same individuals 
confirming repeatability of the assay. 
	
  
  
ANOVA
Source of Variation SS df MS F P‐value F crit
Same sample 16535.68 33 501.0812 96.00666 8.4E‐25 1.787822
Between samples 17.60529 1 17.60529 3.373157 0.075289 4.139252
Error 172.2347 33 5.219234
Total 16725.52 67
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Figure 8:  Bland Altman plot comparing DNA fragmentation obtained from the 
same semen sample processed and scored in duplicate by the same 
technician and within the same Halosperm run (n=34).   
Replicate 1 and replicate 2 from the same semen sample were scored by the same 
technician and the mean DNA fragmentation difference was compared. The x axis 
represents the DNA fragmentation level obtained from replicate 1 and the y axis 
represents the percentage difference in the two replicates.  Each point represents a 
sample analysed by both replicas. 
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Using	 a	 repeated	 measures	 ANOVA,	 the	 variance	 of	 DNA	 fragmentation	 levels	
between	 subjects	 is	 significantly	 different,	 but	 no	 significant	 variance	 is	 seen	
between	different	measurements	of	the	same	individual	(Table	3).	The	mean	DNA	
fragmentation	 percentage	 ±	 SEM	 for	 technician	 1	 was	 22.86±1.28	 and	 for	
technician	2	the	percentage	was	22.65±1.37.	 	Student’s	paired	t‐test	between	the	
two	 replicates	was	 t=0.37;	 p=0.71.	 	 The	Bland‐Altman	plot	 (Figure	9)	 shows	 the	
DNA	fragmentation	difference	between	technician	1	and	technician	2.		
Table 3: Repeated Measures ANOVA showing variance among subjects differs 
significantly from the variance between measures of the same individuals 
confirming repeatability of the assay. 
	
 
 
	
Figure 9: Difference of DNA fragmentation levels between technician 1 and 
technician 2.  
The same semen samples were scored on different occasions by 2 different 
technicians (n=164) 
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6.2 Mean Semen Analysis and DNA Fragmentation Results 
The	 total	number	of	 semen	samples	obtained	 for	 semen	analysis	and	Halosperm	
testing	was	905,	from	a	total	of	863	men.		A	summary	of	the	semen	analysis	results	
and	their	association	to	the	mean	DNA	fragmentation	result	are	shown	in	Table	4.	
Table 4: Summary of semen analysis results and Pearson Correlation to DFL. 
Values are for the 905 semen samples from 863 men. *Significant association.  
Variable Value P Pearson’s r 
Number	of	men	 863
Number	of	semen	samples	 905
DNA	fragmentation	 23.0±0.6
Abstinence	(days±SEM)	 4.1±0.2 0.001* 	0.11	
Volume	(ml±SEM)	
Sperm	concentration	(x106/ml±SEM)	
3.5±0.1
68.6±2.2	
0.159
0.000*	
	
	0.05	
‐0.17	
Sperm	motility	(%±SEM)	
Sperm	morphology	(%±SEM)		
59.0±0.6
14.0±0.2	
0.000*
0.000*	
‐0.30	
‐0.24	
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6.3 Semen Analysis According to Different WHO Semen Analysis 
Guidelines 4th and 5th Editions 
Of	905	samples,	the	number	of	samples	that	were	classified	as	normozoospermic	
according	 to	 the	 4th	 Edition	 was	 385	 whilst	 697	 were	 classified	 as	
normozoospermic	 according	 to	 the	 5th	 Edition	 (Table	 5).	 	 Of	 the	 semen	 samples	
that	were	classified	as	normozoospermic	 in	 the	5th	Edition,	34	were	classified	as	
normoasthenozoospermic,	190	were	classified	as	normoteratozoospermic	and		61	
as	normoasthenoteratozoospermic	in	the	4th	Edition.		Of	the	31	samples	that	were	
classified	by	the	4th	Edition	as	oligozoospermic,	9	were	classified	as		
normozoospermic	 by	 the	 5th	 Edition.	 	 From	 10	 samples	 classified	 as	
oligoasthenozoospermic	according	to	the	4th	Edition,	7	were	classified	differently		
Table 5: Matrix table showing semen analysis when scored following WHO 4th 
Edition and WHO 5th Edition semen analysis criteria. Refer to Table 6 for reference 
guide to abbreviations. 
according	 to	 the	 5th	 Edition;	 1	 sample	 as	 normozoospermic,	 1	 as	
normoasthenozoospermic	 and	 5	 samples	 as	 oligozoospermic.	 	 Of	 85	 samples	
classified	as	normoasthenoteratozoospermic	by	the	4th	Edition,	81	were	classified	
W
HO
 4t
h E
di
tio
n   
   
WHO 5th Edition
N  NA NT NAT O OA OT  OAT  TOTAL
N  385  0 0 0 0 0 0  0  385
NA  34  11 0 0 0 0 0  0  45
NT  190  2 11 0 0 0 0  0  203
NAT  61  13 7 4 0 0 0  0  85
O  9  0 0 0 22 0 0  0  31
OA  1  1 0 0 5 3 0  0  10
OT  10  0 2 0 53 0 12  0  77
OAT  7  5 1 0 19 18 6  13  69
TOTAL  697  32 21 4 99 21 18  13  905
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differently	 by	 the	 5th	 Edition:	 61	 samples	 as	 normozoospermic,	 13	 as	
normoasthenozoospermic	 and	 7	 as	 normoteratozoospermic.	 Similarly,	 12	 of	 77	
samples	 were	 classified	 as	 oligoteratozoospermic	 by	 both	 editions,	 whilst	 53	
samples	were	graded	as	oligozoospermic,	2	as	normoteratozoospermic	and	10	as	
normozoospermic	 by	 the	 5th	 Edition.	 	 From	 69	 samples	 that	 were	 classified	 as	
ologoasthenoteratozoospermic	by	the	4th	Edition,	13	were	classed	the	same	by	the	
5th	 Edition	 whilst	 the	 balance	 was	 graded	 in	 3	 other	 categories:	 10	 as	
normozoospermic,	2	as	normoteratozoospermic	and	53	as	oligozoospermic.	
Table 6: Reference guide to abbreviations used in tables 5, 7 and 8 
Abbreviation	 Nomenclature	 Deviation	from	reference	limits	
N	 Normozoospermia	 All	semen	analysis	criteria	are	within	
reference	limits	
NA	 Normoaesthenozoospermia Progressive	motility	is	outside	of	reference	
limits	
NT	 Normoteratozoospermia Morphology	is	outside	of	reference	limits	
NAT	 Normoaesthenoteratozoospermia Progressive	motility	and	morphology	are	
outside	of	reference	limits	
O	 Oligozoospermia	 Sperm	concentration	is	outside	of	reference	
limits	
	
OA	 Oligoasthenozoospermia Sperm	concentration	and	progressive	
motility	are	outside	of	reference	limits	
	
OT	 Oligoteratozoospermia	 Sperm	concentration	and	morphology	are	
outside	of	reference	limits	
OAT	 Oligoasthenoteratozoospermia Sperm	concentration,	progressive	motility	
and	morphology	are	outside	of	reference	
limits	
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6.4 Relationship between DNA Fragmentation and Semen Analysis 
Table	7	shows	the	number	of	semen	samples	classified	by	semen	quality	according	
to	WHO	semen	analysis	recommendations	4th	and	5th	Editions	and	the	mean	DNA	
Fragmentation	levels	(as	detected	with	the	Halosperm®	G2	Test	Kit)	of	each.			
Table 7: Mean DNA fragmentation levels according to semen quality when 
classified by WHO 4th Edition and WHO 5th Edition semen analysis 
criteria (n=905).  
Values with the same superscript, within the same manual edition are significantly 
different from each other (p<0.05). NS = Not significant. Refer to Table 6 for reference 
guide to abbreviations. 
	
Following	 the	 4th	 Edition	 semen	 analysis	 criteria,	 OAT	 samples	 had	 significantly	
higher	 DNA	 fragmentation	 compared	 to	 oligozoospermic	 samples	 (p<0.01).	
Similarly,	when	samples	were	classified	using	the	5th	Edition	criteria,	OAT	samples	
had	significantly	higher	DNA	fragmentation	compared	to	oligozoospermic	samples	
(p<0.001).		Equally	when	samples	were	classified	using	the	4th	Edition	criteria	with	
a	 concentration	 ≥	 20M/m	 but	 with	 reduced	 motility,	 DNA	 fragmentation	 levels	
were	significantly	higher	than	compared	to	normozoospermic	samples	(p<0.001).		
Again	DNA	fragmentation	levels	were	significantly	higher	in	samples	with	reduced	
 
Semen 
Quality 
WHO 4th Edition WHO 5th Edition Significance 
between 4th & 
5th Editions 
n SDF (%) n SDF (%) p 
O 31 23.3±2.8h 99 27.0±1.7l, o, p NS 
OT 77 27.6±2.0e, i 18 31.0±4.4 NS 
OA 10 28.1±6.4 21 33.4±4.3m NS 
OAT 69 37.0±2.6d, g, h, i 13 46.6±5.8n, p NS 
N 385 17.5±0.6a, b, c, d, e, j  697 20.3±0.6j,k, l, m, n 0.001 
NT 203 21.8±1.2c, f, g 21 29.9±4.9 NS 
NA 45 28.0±3.2a 32 39.4±4.6k, o NS 
NAT 85 30.7±2.1b, f 4 36.1±9.6 NS 
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motility	 alone	 when	 compared	 with	 normozoospermic	 samples	 (p<0.0001)		
classified	under	the	WHO	5th	Edition	guidelines.		
	
Table	 8	 shows	 the	 proportion	 of	 semen	 samples	 classified	 by	 semen	 quality	
according	 to	 WHO	 semen	 analysis	 recommendations	 4th	 and	 5th	 Editions	 which	
gave	 an	 abnormal	 sperm	 DNA	 fragmentation	 result	 as	 detected	 with	 the	
Halosperm	®	G2	Test	Kit.		
Table 8: Proportion of abnormal DNA fragmentation levels (>30%) when 
classified by WHO 4th Edition and WHO 5th Edition semen analysis 
criteria.  
Refer to Table 6 for reference guide to abbreviations. 
 
Semen quality 
Abnormal SDF / Total (%) 
WHO 4th Edition WHO 5th Edition 
O 
OT 
OA 
OAT 
6/31 (19.4%) 
22/77 (28.6%) 
4/10 (40.0%) 
37/69 (53.6%) 
31/99 (31.3%) 
7/18 (38.9%) 
10/21 (47.6%) 
10/13 (76.9%) 
N 
NT 
NA 
NAT 
45/385 (11.7%) 
34/203 (16.8%) 
13/45 (28.9%) 
38/85 (44.7%) 
112/697 (16.0%) 
9/21 (42.9%) 
17/32 (53.1%) 
3/4 (75.0%) 
	
The	 greatest	 percentage	 of	 samples	with	 abnormal	DFLs	 (>30%)	were	 recorded	
where	 each	 of	 sperm	 concentration,	 morphology	 and	 progressive	 motility	 were	
outside	 of	WHO	 reference	 limits	 for	WHO	 4th	 and	 5th	 Editions	 respectively.	 The	
lowest	percentage	of	samples	with	abnormal	DFLs	were	recorded	where	none	of	
these	 semen	 analysis	 parameters	 (concentration,	 morphology	 and	 progressive	
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motility)	 were	 outside	 the	 WHO	 reference	 limits	 for	 WHO	 4th	 and	 5th	 Editions	
respectively.	
	
6.5  Effects of Extrinsic Factors on Air-dried Slides 
6.5.1 Comparing SDF between Different Reconstituting Fluids 
The	 mean	 DNA	 fragmentation	 percentage	 ±	 SEM	 for	 slides	 reconstituted	 with	
PBS+BSA	 solution	 was	 19.74±3.90	 and	 for	 those	 reconstituted	 with	 seminal	
plasma	 the	percentage	was	18.54±3.26.	 	 Student’s	paired	 t‐test	between	 the	 two	
replicates	was	t=1.11;	p=0.29.	Figure	10	shows	the	DNA	fragmentation	percentage	
recorded	for	each	sample	after	the	airdried	sample	was	reconstituted	with	either	
seminal	plasma	or	PBS+BSA.	The	mean	difference	for	the	two	reconstituting	fluids	
was	1.21±1.13%.							
	
Figure 10: Comparing DNA fragmentation levels to determine effects of reconstituting 
fluids.  
Results are from the same original semen samples (n=15) after being air-dried and 
reconstituted with either seminal plasma or PBS+BSA and being processed in the 
same Halosperm run.	
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6.5.2 Comparing SDF Levels between Slide Type 
The	mean	DNA	fragmentation	levels	±	SEM	of	the	semen	air‐dried	on	flat	slides	and	
stored	at	4oC	for	1	day,	was	13.98±1.55%	and	14.39±1.94%	for	those	air‐dried	on	
concave	 slides	 and	 stored	 in	 the	 same	 manner	 for	 the	 same	 amount	 of	 time.	
Student’s	paired	t‐test	between	the	two	slide	types	was	t=‐0.55;	p=0.60.	The	mean	
difference	per	 sample	was	0.41±0.75%.	Figure	11	 shows	 the	DNA	 fragmentation	
percentage	recorded	for	each	sample,	after	being	stored	on	either	a	flat	or	concave	
slide	for	1	day.							
	
Figure 11: Comparing DNA fragmentation levels to determine effects of slide 
type after 1 day. 
Results are from the same original semen samples (n=8) air-dried and stored on either 
a concave or flat slide and processed in the same Halosperm run.  
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The	mean	DNA	fragmentation	 levels	±	SEM	of	 the	semen	air‐dried	 flat	slides	and	
stored	at	4oC	for	7	days	was	16.26±1.74%	and	17.34±2.02%	for	those	air‐dried	on	
concave	 slides.	 	 Student’s	 paired	 t‐test	 between	 the	 two	 slide	 types	was	 t=‐1.56;	
p=0.15.	 The	 mean	 difference	 per	 sample	 was	 1.08±0.69%.	 Figure	 12	 shows	 the	
DNA	 fragmentation	 percentage	 recorded	 for	 each	 sample	 after	 being	 stored	 on	
either	a	flat	or	concave	slide	for	7	days.			
			
	
Figure 12: Comparing DNA fragmentation levels to determine effects of slide 
type after 7 days. 
Results are from the same original semen samples (n=10) air-dried and stored on 
either a concave or flat slide and processed in the same Halosperm run.  
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6.5.3 Comparing SDF between Processing Protocols 
6.5.3.1 Snap Frozen Semen to Fresh Semen  
The	 average	 DNA	 fragmentation	 percentage	 ±	 SEM	 in	 snap	 frozen	 samples	 was	
21.83±3.16	 and	 those	 obtained	 from	 freshly	 ejaculated	 samples	was	 16.33±2.69.	
Student’s	 paired	 t‐test	 between	 the	 snap	 frozen	 and	 fresh	 semen	was	 significant	
(t=5.00;	p=0.0004).	Figure	13	shows	the	DNA	fragmentation	percentage	recorded	
from	 the	 same	 semen	 samples	 that	 were	 tested	 using	 either	 fresh	 semen	 or	
following	snap	freezing.	The	Bland‐Altman	plot	(Figure	14)	shows	the	mean	DNA	
fragmentation	difference	between	the	two	protocols.		
				
		
Figure 13: Comparing DNA fragmentation levels of snap frozen and fresh semen.  
Both protocols originate from the same semen sample (n=12) and were processed in 
the same Halosperm run.  
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Figure 14: Mean DNA fragmentation differences between snap frozen semen and 
fresh semen.   
Both protocols originate from the same semen sample (n=12) and were processed in 
the same Halosperm run. 
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6.5.3.2 Air-dried Semen to Fresh Semen 
The	average	DNA	fragmentation	percentage	±	SEM	in	air‐dried	semen	samples	was	
20.17±4.54	 and	 those	 obtained	 from	 freshly	 ejaculated	 samples	was	 19.09±4.77.	
Student’s	paired	t‐test	between	the	air‐dried	and	fresh	semen	was	t=1.65;	p=0.12.	
Figure	 15	 shows	 the	 DNA	 fragmentation	 percentage	 recorded	 from	 the	 same	
semen	 samples	 that	 were	 tested	 using	 fresh	 semen	 or	 following	 air‐drying.	
Considering	 the	 Bland‐Altman	 plot	 (Figure	 16)	 the	 mean	 difference	 per	 sample	
was	1.08±0.65%.											
	
Figure 15: Comparing DNA fragmentation levels of air-dried semen and fresh 
semen.   
Both protocols originate from the same semen sample (n=13) and were processed in 
the same Halosperm run. 
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Figure 16: Mean DNA fragmentation differences between air-dried semen and 
fresh semen.   
Both protocols originate from the same semen sample (n=13) and were processed in 
the same Halosperm run. 
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6.5.4 Comparing SDF between Different Times and Temperatures 
6.5.4.1 Air-dried Semen Stored at Room Temperature: 1 Day 
compared to 7 Days 
The	mean	DNA	 fragmentation	 levels	 ±	 SEM	of	 the	 semen	air‐dried	and	 stored	 at	
room	 temperature	 for	 1	 day,	 was	 23.95±4.40%	 and	 70.25±8.58%	 for	 those	 air‐
dried	and	stored	in	the	same	manner	for	7	days.		Student’s	paired	t‐test	between	1	
day	 and	 7	 days	 was	 t=‐5.08;	 p=0.0005.	 The	 mean	 difference	 per	 sample	 was	
46.29±9.12%.		Figure	17	shows	the	DNA	fragmentation	percentage	recorded	from	
the	same	semen	samples	that	were	air‐dried	and	stored	at	room	temperature	for	
either	1	day	or	7	days.					
	
	
Figure 17: DNA fragmentation levels of air-dried semen stored at room 
temperature for 1 and 7 days.   
Both protocols originate from the same semen sample (n=11) and were processed in 
the same Halosperm run. 
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6.5.4.3 Air-dried Semen Stored at 4oC: 1 Day compared to 30 
Days 
The	mean	DNA	 fragmentation	 levels	 ±	 SEM	of	 the	 semen	air‐dried	and	 stored	 at	
4oC	for	1	day,	was	11.37±1.66%	and	30.96±5.32%	for	those	air‐dried	and	stored	in	
the	same	manner	for	30	days.		Student’s	paired	t‐test	between	1	day	and	30	days	
was	 significant	 (t=‐3.42;	 p=0.007).	 The	 mean	 difference	 per	 sample	 was	
19.59±5.72%.	Figure	19	shows	the	DNA	fragmentation	percentage	recorded	from	
the	same	semen	samples	that	were	air‐dried	and	stored	at	4oC	for	either	1	day	or	
30	days.				
	
Figure 19: DNA fragmentation levels of air-dried semen stored at 4oC for 1 and 30 
days.   
Both protocols originate from the same semen sample (n=10) and were processed in 
the same Halosperm run. 
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6.5.4.4 Air-dried Semen Stored at -22oC: 1 Day compared to 30 
Days 
The	mean	DNA	fragmentation	levels	±	SEM	of	the	semen	air‐dried	and	stored	at		
‐22oC	for	1	day	was	22.81±4.20%	and	23.22±3.84%	for	those	air‐dried	and	stored	
in	the	same	manner	for	30	days.		Student’s	paired	t‐test	between	1	day	and	30	days	
was	 t‐0.75;	 p=0.47.	 The	mean	 difference	 per	 sample	was	 0.68±0.53%.	 Figure	 20	
shows	the	DNA	fragmentation	percentage	recorded	from	the	same	semen	samples	
that	were	air‐dried	and	stored	at	‐22oC	for	either	1	day	or	30	days.					
	
	
Figure 20: DNA fragmentation levels of air-dried semen stored at -22oC for 1 and 
30 days.   
Both protocols originate from the same semen sample (n=11) and were processed in 
the same Halosperm run. 
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6.5.4.5 Air-dried Semen Stored over Time at -22oC 
Figure	 21	 shows	 results	 from	 the	 first	 and	 second	 batch	 of	 high	 value	 DNA	
fragmentation	 quality	 control	 samples,	 ‘QC1	 High’	 and	 ‘QC2	 High’	 respectively.	
DNA	fragmentation	levels	for	‘QC1	High’	were	recorded	at	67%	after	2	days	in		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure 21: DNA fragmentation levels of ‘QC1 High’ (A) and ‘QC2 High’ (B) high 
value quality control samples measured at different time points from 
air-dried slides stored at -22oC.   
‘QC1 High’ and ‘QC2 High’ originate from different semen samples.  All ‘QC1 High’ 
samples were stored on the same day, as were all ‘QC2 High’ samples.	
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storage,	69%	after	7	days	 in	storage,	79%	after	16	days	 in	storage,	74%	after	28	
days	in	storage	and	82%	after	37	days	in	storage.		The	results	from	‘QC2	High’	for	
similar	time	frames	as	‘QC1	High’	were	52%	after	14	days	in	storage,	40%	after	28	
days	in	storage	and	45%	after	35	days	in	storage.		For	‘QC1	High’	the	mean	DFL	±	
SEM	for	samples	stored	up	to	28	days	was	75.01±2.12	compared	to	78.15±3.85	for	
samples	stored	between	28	and	41	days,	 resulting	 in	a	4%	 increase	between	 the	
two	time	frames.		The	mean	DFL	±	SEM	for	‘QC2	High’	was		46.53±3.57	for	samples	
stored	up	to	28	days	and	47.83±4.56	for	samples	stored	between	28	and	41	days,	
resulting	in	a		3%	increase	between	the	two	time	frames.		
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Figure	22	shows	results	from	the	first	batch	(A)	and	second	batch	(B)	of	low	value	
DNA	fragmentation	quality	control	samples,	‘QC1	Low’	and	‘QC2	Low’	respectively.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure 22: DNA fragmentation levels of ‘QC1 Low’ (A) and ‘QC2 Low’ (B) low 
value quality control samples measured at different time points from 
air-dried slides stored at -22oC.   
‘QC1 Low’ and ‘QC2 Low’ originate from different semen samples.  All ‘QC1 Low’ 
samples were stored on the same day, as were all ‘QC2 Low’ samples. 
	
DNA	 fragmentation	 levels	 for	 ‘QC1	 Low’	 were	 recorded	 at	 14%	 after	 2	 days	 in	
storage,	18%	after	16	days	in	storage,	23%	after	28	days	in	storage	and	72%	after	
37	 days	 in	 storage.	 	 The	 results	 from	 ‘QC2	Low’	 for	 similar	 time	 frames	 as	 ‘QC1	
Low’	were	23%	after	14	days	 in	 storage,	25%	after	28	days	 in	 storage	and	42%	
after	35	days	in	storage.		For	‘QC1	Low’	the	mean	DFL	±	SEM	for	samples	stored	up	
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to	28	days	was	17.81±1.14	compared	to	47.10±24.50	for	samples	stored	between	
28	and	41	days,	resulting	 in	a	164%	increase	between	the	two	time	frames.	 	The	
mean	DFL	±	SEM	for	‘QC2	Low’	was		23.97±0.38	for	samples	stored	up	to	28	days	
and	39.70±6.76	 for	 samples	 stored	between	28	and	41	days,	 resulting	 in	a	 	66%	
increase	between	the	two	time	frames.	Figure	23	shows	the	rapid	increase	in	DNA	
fragmentation	after	28	days	storage.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 
Figure 23: DNA fragmentation levels of ‘QC1 Low’ (A) and ‘QC2 Low’ (B) low 
value quality control samples measured after 28 days storage to show 
rapid increase in fragmentation after this time point. 
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7  Discussion 
7.1 Summary 
There	were	two	major	purposes	of	this	study.		The	first	was	to	consider	the	clinical	
utility	 of	 the	 Halosperm	 assay	 by	 investigating	 the	 relationship	 between	 DNA	
integrity	 and	 semen	 analysis.	 	 The	main	 finding	 was	 that	 DNA	 fragmentation	 is	
more	prevalent	in	abnormal	semen	samples	when	considering	both	WHO	4th	and	
5th	Edition	semen	analysis	criteria.		Conversely,	elevated	DNA	fragmentation	levels	
have	been	found	in	normal	semen	samples	using	the	same	criteria.		From	this	it	can	
be	 concluded	 that	 the	 Halosperm	 test	 provides	 additional	 information	 over	 and	
above	semen	analysis	and	therefore	is	a	valuable	adjunct	to	semen	analysis	 in	an	
andrology	laboratory.			
	
The	 second	purpose	of	 this	 study	was	 to	develop	an	alternative	method	 to	 store	
sperm,	over	a	period	of	 time,	prior	 to	DNA	 integrity	 testing	using	 the	Halosperm	
assay.	 	 This	 was	 achieved	 by	 air‐drying	 whole	 semen	 samples	 onto	 microscope	
slides	 and	 storing	 the	 slides	 at	 ‐22oC	 for	 one	month	whilst	maintaining	 the	DNA	
integrity	of	that	sample.	
	
7.2 Clinical Utility of the Halosperm® G2 Kit  
The	first	research	question	asked	what	relationships	exist	between	semen	quality	
(according	 to	 both	 the	WHO	 4th	 and	 5th	 Edition	 semen	 analysis	 guidelines)	 and	
DNA	fragmentation	levels	as	detected	by	the	Halosperm®	G2	Kit.		The	results	from	
this	study	indicate	that	DNA	fragmentation	levels,	defined	by	the	Halosperm	assay,	
are	 significantly	 higher	 in	 samples	 categorised	 as	 abnormal	 than	 those	 samples	
which	were	 categorised	 as	 having	 a	 normal	 semen	 analysis,	 regardless	 of	which	
guidelines	were	used.	 	Semen	samples	categorised	as	OAT	by	both	WHO	editions	
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have	 the	 highest	 DNA	 damage	 load	 compared	 to	 those	 of	 oligozoospermic,	
asthenozoospermic	 and	 teratozoospermic	 samples.	 	 Whilst	 the	 compounding	
effects	 of	 	 impaired	 parameters	 (concentration,	 morphology	 and	 motility)	 may	
increase	 fragmentation	 levels,	 11.7%	 and	 16.0%	 of	 samples	 classified	 as	
normozoospermic	in	WHO	4th	and	5th	Edition	guidelines	respectively	had	elevated	
DFLs.	 	 Furthermore,	 there	 was	 a	 statistically	 significant	 difference	 in	 DNA	
fragmentation	 levels	 for	 these	 samples.	 	 There	 was	 however,	 no	 statistical	
difference	between	the	WHO	4th	and	5th	Edition	guidelines	for	DNA	fragmentation	
levels	 of	 specifically	 categorised	 semen	 defects.	 	 All	 samples	 scored	 using	 5th	
Edition	 criteria,	with	 some	 abnormality	 in	 terms	 of	motility	 and/or	morphology	
showed	a	mean	abnormal	DNA	fragmentation	result.		In	contrast,	using	4th	Edition	
criteria,	only	samples	with	both	abnormal	motility	and	morphology	show	a	mean	
abnormal	DNA	fragmentation	result.	Whilst	no	studies	have	considered	all	of	these	
same	parameters,	the	general	finding	that	there	is		a	relationship	between	DFL	and	
sperm	motilily	 and	morphology	 is	 in	agreement	with	other	 reports	 (Irvine	et	al.,	
2000;	 Lopes	 et	 al.,	 1998;	Mangiarini	 et	 al.,	 2013;	 Peluso	 et	 al.,	 2013;	 Velez	 de	 la	
Calle	et	al.,	2008).			
	
Interestingly	 the	mean	DNA	 fragmentation	 level	 for	 samples	with	only	 abnormal	
concentration	levels	were	within	normal	limits	when	using	both	4th	and	5th	Edition	
semen	 analysis	 criteria.	 	 Irvine	 et	 al.,	 (2000)	 also	 concluded	 that	 DNA	
fragmentation	 levels	 were	 within	 normal	 limits	 when	 sperm	 concentration	 was	
below	 normal	 limits,	 when	 they	 followed	 the	 WHO	 3rd	 Edition	 semen	 analysis	
criteria.	 Since	 the	 guidelines	 of	 the	WHO	 3rd	 and	 4th	 Editions	 provide	 the	 same	
sperm	 concentration	 criteria	 (Esteves	 et	 al.,	 2011)	 the	 use	 of	 a	 different	manual	
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was	not	considered	relevant.	They	did	however	use	the	Comet	assay	to	 interpret	
DNA	fragmentation	levels	and	as	such	a	direct	comparison	between	this	study	and	
that	of	Irvine	and	colleagues	should	be	considered	cautiously.		
	
The	 actual	 proportion	 of	 normozoospermic	 samples	 with	 abnormal	 DNA	
fragmentation	 levels	 (>30%)	were	 11.7%	 and	 16%	 following	 4th	 and	 5th	 Edition	
guidelines	 respectively,	which	 concurs	with	others’	 findings	 (Omran	 et	 al.,	 2013;	
Schulte	 et	 al.,	 2010)	 that	 15%	 of	 infertile	 men	 have	 semen	 within	 normal	
parameters.	 	 This	 demonstrates	 that	 the	Halosperm	 assay	 can	 explain	 infertility	
where	semen	analysis	cannot.	
	
The	proportion	of	abnormal	semen	samples	with	high	DNA	fragmentation	levels	is	
higher	when	semen	analysis	is	measured	using	the	5th	Edition	compared	to	semen	
analysed	using	4th	 Edition	 criteria.	 	 Consequently,	 there	 is	 considerable	 risk	 that	
DNA	 damaged	 spermatozoa	 could	 be	 used	 in	 ART.	 	 In	 considering	 this,	 it	 is	
proposed	 that	 the	 inclusion	 of	 the	 Halosperm	 assay,	 particularly	 where	
laboratories	 are	 using	 5th	 Edition	 guidelines,	 is	 necessary	 when	 diagnosing	
infertility	and	planning	treatment	options.			
	
7.3 Quality Control and Assay Precision 
As	with	all	diagnostic	tests,	corroboration	between	technicians’	testing	procedures	
and	interpretation	of	results	within	andrology	laboratories	is	an	important	factor	
to	be	considered	(Matson,	1997).		In	order	to	establish	the	potential	fertility	status	
of	a	semen	sample	accurately,	 the	method	of	analysis	must	have	specific,	precise	
and	 objective	 parameters	 that	 allow	 for	 a	 correlation	 of	 the	 data	 to	 be	 to	
recognised	and	validated.	Furthermore,	analysing	the	internal	sources	of	potential	
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error	 such	 as	 results	 produced	 by	 the	 same	 technician	 and	 those	 between	
technicians,	 are	 paramount	 to	 confirm	 the	 validity	 of	 any	 study	 (Franken	 &	
Oehninger,	2012).			
	
In	 this	 present	 study	 it	 was	 apparent	 that	 there	 was	 some	 variability	 between	
different	 Halosperm	 runs	 using	 the	 same	 samples.	 The	 greatest	 variability	 was	
evident	 at	 the	 lower	 values	 which	 is	 similar	 to	 that	 seen	 with	 semen	 analysis	
(Leushuis	et	al.,	2010).	
	
Intra	 assay	 variability	 appears	 to	 be	 different	 dependent	 on	 which	 DNA	
fragmentation	assay	is	being	used,	with	previous	studies	reporting	this	to	be	either	
small	 but	 significantly	 different	 with	 the	 TUNEL	 assay	 (Sharma	 et	 al.,	 2010)	 or	
small	and	not	significantly	different	using	a	modified	Comet	assay	(Hughes,	Lewis,	
McKelvey‐Martin,	&	Thompson,	 1997)	 and	 no	 difference	 using	 the	 SCSA	method	
(Erenpreiss	 et	 al.,	 2006).	 	 It	 is	 not	 surprising	 therefore	 that	 the	 results	 of	 this	
present	 study	 show	 some	 variability.	 As	 the	mechanisms	 behind	 such	 variations	
remain	 unclear,	 it	 is	 difficult	 to	 speculate	 why	 intra	 assay	 variability	 exists,	
particularly	when	the	same	semen	sample	is	used.	Data	from	Cortes	and	colleagues	
(2010)	has	shown	that	DNA	fragmentation	 levels	 in	semen,	when	measured	with	
the	SCD	test	are	not	consistent	within	a	male	over	different	time	frames	and	that	
such	variation	is	similar	in	scale	to	that	which	can	be	seen	between	individuals.	It	
seemed	obvious	therefore,	that	where	different	protocols	were	being	compared,	it	
was	necessary	that	each	protocol	be	tested	and	run	in	the	same	Halosperm	batch	
assay.			
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Having	considered	between	run	variability,	within‐run	variability	was	assessed.		In	
this	 study	 no	 significant	 variation	 was	 seen	 in	 DFI	 (DNA	 fragmentation	 Index)	
when	the	same	semen	sample	was	tested	in	duplicate	within	the	same	batch	assay.		
This	is	correlates	with	other	reports	that	have	tested	more	than	one	aliquot	of	the	
same	 semen	 sample	 in	 the	 same	batch	 assay	 (Shamsi	 et	 al.,	 2010;	 Sharma	et	 al.,	
2010)	 	although	again	different	DNA	fragmentation	assays	were	used.	 	Following	
this,	 inter‐observer	 variability	 (results	 from	 one	 technician	 compared	 to	 those	
from	another	technician	for	the	same	samples)	was	found	to	be	very	similar	and	as	
such	the	quality	assurance	of	this	present	study	was	confirmed.	
				
7.4 Reconstitution Media 
In	the	present	study	it	was	clear	that	both	seminal	plasma	and	phosphate	buffered	
saline	plus	bovine	 serum	albumin	 solution	 (PBS+BSA)	were	effective	methods	of	
reconstituting	air‐dried	semen.	 	The	primary	aim	of	comparing	the	reconstitution	
fluids	 was	 to	 establish	 if	 a	 readily	 available	 solution	 could	 be	 used	 without	
affecting	DNA	fragmentation	levels	of	air‐dried	semen.	Bovine	serum	albumin	is	a	
very	 stable	 serum	which	 not	 only	 stabilizes	 proteins	whilst	 in	 solution	 but	 also	
prevents	non‐specific	binding	to	laboratory	equipment.		The	serum	also	acts	as	an	
extracellular	antioxidant	which	is	useful	for	the	elimination	of	free	radicals	which	
could	potentially	cause	DNA	damage	(Namasivayam	et	al.,	2013).	 	 In	the	 forensic	
setting	 PBS	 is	 commonly	 combined	 with	 saliva	 and	 semen	 stains	 prior	 to	 DNA	
extraction	 (Alvarez,	 Juusola,	 &	 Ballantyne,	 2004)	 and	 therefore	 it	 was	 expected	
that	 the	PBS+BSA	solution	would	have	no	detrimental	 effect	on	DNA	 integrity	of	
air‐dried	semen.							
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Recent	 research	 assessed	 the	 stability	 of	 DNA	 integrity	 after	 air‐drying	 semen	
using	 seminal	plasma	as	 the	 reconstituting	 fluid	 (Yap	&	Matson,	2012),	 however	
these	 authors	 did	 not	 consider	 the	 effects	 of	 PBS+BSA	 solution.	 	 In	 the	 present	
study,	it	was	found	that	reconstituting	air‐dried	semen	with	PBS+BSA	had	several	
advantages	 over	 seminal	 plasma:	 Firstly,	 the	 use	 of	 seminal	 plasma	 required	 a	
sufficient	ejaculate	volume	to	be	able	to	air‐dry	samples	and	centrifuge	the	balance	
to	 enable	 the	 separation	 of	 seminal	 plasma	 from	 sperm	 whereas	 PBS+BSA	 is	
readily	available.		Secondly,	the	air‐dried	semen	became	homogenous	quickly	and	
easily,	 without	 the	 need	 for	 prolonged	 mixing	 when	 the	 PBS+BSA	 solution	 was	
used	 as	 the	 reconstituting	 fluid,	 compared	 to	 seminal	 plasma	 which	 required	
extensive	mixing.		Thirdly,	the	time	to	separate	spermatozoa	from	seminal	plasma	
and	 confirm	 that	 no	 spermatozoa	 remain	 was	 disruptive	 to	 the	 andrology	
laboratory	with	regards	to	centrifuge	availability,	as	was	technician	time.	This	was	
not	 a	 problem	 with	 PBS+BSA.	 	 Finally,	 the	 antibacterial	 properties	 of	 seminal	
plasma	 diminish	 greatly	 over	 time	 resulting	 in	 a	 short	 shelf	 life	 (Edström	 et	 al.,	
2008)	whereas	PBS+BSA	can	be	stored	in	an	airtight	container	for	several	months	
at	4oC.		
	
7.5 Effect of Slide Type  
The	 present	 study	 has	 demonstrated	 no	 significant	 difference	 in	 DNA	 integrity	
when	 semen	 was	 air‐dried	 on	 flat	 or	 concave	 microscope	 slides.	 	 There	 was	
however	a	marked	difference	in	the	ease	of	reconstituting	the	air‐dried	semen	in	
the	confines	of	the	concave	as	opposed	to	the	flat	surface.		Furthermore	collection	
of	the	25l	was	substantially	easier	from	the	concave	slide	with	air	bubbles	being	
fairly	common	when	collecting	resuspended	semen	off	flat	microscope	slides.		This	
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was	 particularly	 evident	 if	 the	 angle	 of	 the	 slide	 was	 not	 sufficient	 to	 pool	 the	
semen	without	 it	 running	 off	 the	 slide.	 	 On	 flat	 slides,	 the	 edges	 of	 the	 air‐dried	
semen	 pool	 on	 occasions	 became	 flaky	 whereas	 the	 air‐dried	 semen	 pool	 on	
concave	slides	 remained	consistently	uniform.	 	 It	 is	possible	 that	 flakes	breaking	
away	 from	 the	 original	 pool	 could	 potentially	 contaminate	 other	 samples	 and	 is	
therefore	considered	to	be	a	distinct	disadvantage.					
	
7.6 Snap Frozen Semen Storage 
The	 DNA	 fragmentation	 levels	 of	 the	 snap	 frozen	 versus	 fresh	 semen	 sample	
experiment	 indicate	 that	 snap	 freezing	 induces	 DNA	 fragmentation,	 with	 the	
results	 showing	 a	 significant	 decline	 in	DNA	 integrity	 following	 snap	 freezing	 of		
the	 same	 fresh	 sample.	 	 This	 is	 in	 accordance	 with	 results	 from	 Jackson	 et	 al.,	
(2010)	who	reported	a	significant	decrease	 in	DNA	 integrity	using	the	SCD	assay	
after	 snap	 freezing.	 	 In	 contrast,	Wakefield	 and	 colleagues	 (2010)	 reported	 that	
snap	 freezing	 had	 no	 effect	 on	 the	 result	 of	 DNA	 fragmentation	when	 using	 the	
SCSA	 assay.	 	 This	 difference	 may	 be	 accounted	 for	 by	 the	 different	 methods	 of	
thawing.		Wakefield	et	al.,	(2010)	thawed	the	semen	rapidly	in	a	water	bath	at	37oC	
for	30	seconds,	whilst	this	present	study		thawed	the	samples	at	room	temperature	
for	30	to	60	minutes	(refer	chapter	5.5.2).	Jackson	and	colleagues	did	not	however	
disclose	 their	 thawing	method.	 	 The	 slow	 thaw	 option	was	 used	 in	 this	 present	
study	for	two	reasons:	the	first	from	a	safety	perspective	as	there	was	less	risk	of	
the	nunc	cryovial	exploding	and	secondly	 to	prevent	DNA	damage	caused	by	 the	
heat	 of	 the	 water	 bath.	 	 The	 method	 of	 DNA	 fragmentation	 analysis	 used	 by	
Wakefield	 et	 al.,	 is	 unlikely	 to	 have	 had	 an	 effect	 on	 the	 differing	 fragmentation	
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levels	since	SCSA	and	SCD	produce	statistically	similar	results	(Chohan	et	al.,	2006;	
Ebner	et	al.,	2011;	Velez	de	la	Calle	et	al.,	2008).		
	
	
7.7 Air-dried Semen Storage 
In	the	present	study	no	significant	variation	between	DNA	fragmentation	levels	of	
fresh	semen	and	air‐dried	semen	were	observed.	This	study	has	also	demonstrated	
that	air‐dried	semen	can	be	stored	for	up	to	one	week	at	4oC	and	up	to	one	month	
at	 ‐22oC	 with	 only	 slight	 (non‐significant)	 changes	 to	 the	 DNA	 integrity.	 	 The	
presence	 of	 some	 DNA	 degradation	 within	 the	 air‐dried	 semen	 sample	 is	
consistent	 with	 previous	 research	 in	 the	 forensic	 setting	 using	 saliva.	 	 Such	
research	 has	 shown	 that	 DNA	 can	 be	 successfully	 extracted	 and	 analysed	 from	
fresh	saliva	that	was	stored	for	one	week	at	4oC	and	‐20oC	and	from	saliva	stored	at	
‐20oC	for	20	days	(Walsh	et	al.,	1992).			
	
Whilst	 there	was	no	significant	change	 in	DFL	when	air‐dried	semen	slides	were	
stored	 at	 ‐22oC	 for	 30	 days,	 there	was	 a	 significant	 decline	when	 samples	were	
stored	 for	 this	 time	 period	 at	 4oC.	 	 Furthermore	 the	DFLs,	 of	 the	 two	 low	 value	
quality	 control	 samples	 post	 28	 days	 storage,	 increased	 substantially	 over	 those	
recorded	 up	 to	 28	 days	 of	 storage.	 This	 data	 suggests	 that	 the	 DNA	 in	 air‐dried	
samples	 does	 degrade;	 the	 pace	 of	 which	 being	 dependent	 on	 the	 temperature	
used	for	storage.		In	this	present	study	DNA	degradation	is	far	slower	at	‐22oC	than	
at	4oC	showing	that	the	colder	temperature	is	more	effective	at	slowing	down	DNA	
degradation.	It	is	therefore	recommended	that	whilst	air‐dried	semen	samples	can	
be	stored	at	‐22oC	for	up	to	one	month,	this	method	of	storage	is	not	suitable	for	
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longer	term	storage	and	may	therefore	not	suffice	for	use	in	internal	and	external	
quality	assurance	programs.	
		
The	high	value	control	samples	produced	erratic	changes	which	may	be	explained	
by	the	degree	of	sperm	DNA	integrity	having	an	influence	on	the	stability	of	the	air‐
dried	samples	and/or	being	vulnerable	to	the	freeze	thawing	process.	 	Since	only	
two	samples	were	available	 for	analysis	however,	 caution	should	be	exercised	 in	
this	 regard.	 	 These	 results	 indicate	 that	 frozen‐thawed	 samples	with	 excessively	
high	DFLs	are	not	stable	when	air‐dried	and	stored	at	‐22oC.						
			
8 Limitations and Future Studies 
One	 particular	 limitation	 of	 this	 study	 was	 the	 need	 to	 snap	 freeze	 all	 semen	
samples	 in	 order	 to	 run	 DNA	 fragmentation	 analysis	 on	 different	 storage	 time	
protocols	within	the	same	batch	assay.		Spermatozoa	from	infertile	men	are	more	
susceptible	 to	 the	 freeze	 thawing	 process	 with	 DNA	 fragmentation	 levels	
increasing	 significantly	 more	 than	 in	 their	 fertile	 counterparts.	 Whilst	 this	 is	
unlikely	to	have	affected	the	difference	in	fragmentation	levels	between	protocols,	
the	writer	 is	 aware	 that	 snap	 freezing	 does	 induce	 some	DNA	 damage	 and	may	
have	exacerbated	the	level	of	DNA	degradation.			
	
Another	 limitation	 of	 this	 study	 was	 with	 the	 test	 involving	 the	 high	 and	 low	
quality	control	samples	to	measure	changes	in	DNA	fragmentation	over	time.		This	
test	was	not	purposefully	designed	but	high	and	low	quality	control	samples	were	
included	 in	 routine	 clinical	 analysis	 where	 space	 within	 the	 assay	 run	 was	
available.		There	was	therefore	no	way	of	ensuring	consistant	gaps	in	time	between	
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analyses	 as	 the	 timing	of	 these	 tests	were	dictated	by	when	 the	 routine	 analysis	
was	conducted	and	where	space	within	the	assay	run	was	available.		Consequently	
the	sample	size	was	small,	limiting	the	statistical	power	of	these	results.			
	
Future	 studies	 using	 fresh	 (as	 opposed	 to	 frozen‐thawed)	 semen	 prior	 to	 air‐
drying	 are	 now	 required.	 	 This	 will	 be	 further	 improved	 by	 a	 purposely	
constructed	 study	 to	 measure	 change	 in	 DNA	 fragmentation	 over	 time	 using	
consecutive	daily	analysis	on	a	larger	sample	size	to	determine	at	what	time	frame	
significant	 changes	 in	 the	DNA	 integrity	are	observed	when	semen	has	been	air‐
dried	and	stored	at	‐22oC.	
	
9 Conclusion  
In	 conclusion,	 the	Halosperm	assay	has	been	 shown	 to	be	 clinically	useful	 in	 the	
diagnosis	of	male	infertility,	particularly	idiopathic	infertility.		The	test	is	useful,	in	
that	 it	 is	 reproducible;	each	 time	a	 sample	 is	 tested	 in	 the	same	batch	assay,	 the	
results	are	similar	and	it	provides	additional	information	over	and	above	standard	
semen	analysis.		Additionally,	this	study	has	shown	that	semen	can	be	air‐dried	on	
concave	microscope	slides	and	stored	for	up	to	one	month	at	‐22oC,	before	being	
reconstituted	with	a	 readily	available	 reconstituting	 fluid	without	any	 significant	
DNA	degradation	when	 tested	with	 the	Halosperm	assay.	 	More	 importantly,	 air‐
dried	slides	provide	statistically	closer	DNA	fragmentation	results	to	those	of	fresh	
samples,	than	to	those	of	frozen	samples.		Not	only	is	this	a	simple	method	to	store	
semen	prior	to	DNA	integrity	testing	but	the	results	are	more	accurate	than	when	
current	methods	of	storage	are	used.  
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Appendix I: Participant Information Sheet and Consent Form
  
	
	
	
RESEARCH	PROJECT	INFORMATION	
	
This	research	project	is	being	conducted	by	Ashleigh	McEvoy	as	part	of	the		
requirements	of	a	Masters	Degree	(MSc)	at	Edith	Cowan	University.		
The	title	for	this	student	research	project	is:	
The	development	of	a	simplified	method	of	human	semen	
storage	for	the	testing	of	sperm	DNA	fragmentation		
	
Background	
1. Increased	levels	of	sperm	DNA	fragmentation	are	associated	with	reduced	
male	fertility.	
2. Sperm	DNA	fragmentation	is	assessed	routinely	at	Fertility	North	with	a	
commercially‐available	method,	the	Halosperm	kit.	
3. Tests	are	run	twice	per	week,	with	samples	being	stored	in	liquid	nitrogen	
ready	for	batch	testing.	
4. Quality	control	samples	are	kept	in	liquid	nitrogen	for	inclusion	each	time	
the	test	is	run.	
5. Liquid	nitrogen	is	not	an	ideal	method	of	storage	as	it	is	dangerous	to	use,	
and	quality	control	samples	take	up	a	large	amount	of	storage	space.	
	
Aim	of	the	project	
a) The	present	study	will	investigate	the	possibility	of	using	air‐dried	slides	to	
store	semen	samples	prior	to	testing.	
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b) The	results	of	the	air‐dried	samples	will	be	compared	with	the	same	sample	
stored	in	liquid	nitrogen	in	the	usual	way.	
c) Only	once	we	are	confident	that	we	get	the	same	results	will	we	be	able	to	
introduce	air‐drying	in	to	routine	practice.	
	
How	can	you	help?	
Once	your	semen	sample	has	been	analysed	in	the	normal	way,	we	would	like	to	
use	the	remainder	of	the	sample	in	the	project	rather	than	it	being	discarded.	
	
How	will	the	sample	be	used?	
Your	semen	sample	will	have	some	stored	in	liquid	nitrogen,	and	some	air‐dried	on	
a	microscope	slide.	Both	will	then	be	tested	in	the	Halosperm	test.	Your	sperm	
from	both	the	liquid	nitrogen	and	the	air‐dried	slide	will	be	discarded	once	the	
investigation	is	complete.	It	will	NOT	be	used	for	insemination	or	to	achieve	a	
pregnancy.		
	
Will	I	get	to	see	the	results?	
If	you	agree	for	your	sample	to	be	used	then	we	shall	send	you	a	copy	of	the	final	
report	of	the	project.	
	
Will	the	study	help	me?	
Not	directly	as	the	results	will	not	affect	your	treatment	or	management.	However,	
it	will	hopefully	enable	us	to	improve	techniques	in	the	future,	which	will	be	of	
benefit	to	everyone	seeking	treatment.	
	
Who	will	see	the	results	of	my	sample?	
The	sample	will	be	coded	so	that	your	identity	will	only	be	known	by	the	staff	at	
Fertility	North.	Please	note	that	no	other	samples	from	you	will	be	used.	
	
What	if	I	do	not	want	my	sample	to	be	used?	
You	are	free	to	refuse	for	your	sample	to	be	used.	This	will	not	prejudice	your	
treatment	in	any	way.	
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Who	should	I	ask	if	there	are	any	questions?	
Dr	Phillip	Matson	(Scientific	Director)	and	Dr	Vince	Chapple	(Medical	Director)	are	
the	senior	people	involved	in	the	project.	These,	or	any	of	the	laboratory	staff	at	
Fertility	North,	will	be	happy	to	answer	any	questions	or	queries.	If	you	require	
assistance,	call	Dr	Matson	on	9301	1075.	
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FNC	22.	 CONSENT	FOR	THE	USE	OF	SEMEN	IN	THE	RESEARCH	PROJECT		
ENTITLED:	
The	development	of	a	simplified	method	of	human	semen	storage	for	the	
testing	of	sperm	DNA	fragmentation.	
	
Name:		 ……………………………………………………………..	
Address:	 ……………………………………………………………..	
DOB:	 	 ……………………..	
I	agree	for	my	semen	sample	produced	on	(date)…………...…	to	be	used	in	this	
project.	
I	also	understand	that:	
a) Refusal	would	not	have	prejudiced	my	treatment	in	any	way.	
b) My	sperm	will	NOT	be	used	to	achieve	a	pregnancy,	but	will	be	discarded	
upon	completion	of	the	investigation.	
c) I	will	be	sent	a	copy	of	the	final	report	of	the	study	so	that	I	may	see	how	the	
semen	samples	were	used,	and	the	conclusions	made.	
d) I	am	free	to	ask	questions	of	the	investigators	during	the	study.	
e) I	will	be	given	a	copy	of	this	consent	form.	
	
	
SIGNATURES	
Volunteer:	…………………………………………..							date	………………..	
Witness:	……………………………………………..						date	………………..	
(Must	be	FN	member	of	staff)	
	
The	ethical	aspects	of	this	study	have	been	approved	by	the	Joondalup	Health	Campus	
Human	Research	Ethics	Committee.		If	you	have	any	complaints	or	reservations	about	
any	ethical	aspect	of	your	participation	in	this	research,	you	may	contact	the	
Committee	through	the	Executive	Office	–	phone	9400	9404.		Any	complaint	you	
make	will	be	treated	in	confidence	and	investigated,	and	you	will	be	informed	of	the	
outcome	
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Appendix II: SOP Halosperm Testing  
Purpose:	To	describe	in	detail	the	procedure	for	the	assessment	of	sperm	DNA	
fragmentation	in	humans	using	the	Halosperm	G2	Test	Kit.	
	
Associated	Documents:
LB‐F‐398:02	 Halosperm	Worksheet
LB‐S‐493	 Semen	Analysis
	
Definitions:	
	 	
	 	
	
Responsibilities:	 	
Role	 or	
Department	 Responsible	for:	
	
Andrology	
	
 Ensuring	that	this	procedure	is	adhered	to	in	relation	
to	DNA	fragmentation	testing	
1	 Introduction 
1.1	 The	SCD	assay	determines	the	vulnerability	of	sperm	DNA	to	acid	
	 denaturation	and	follows	the	principle	that	induced	condensation	is	directly	
	 related	to	sperm	DNA	fragmentation	(Muriel	et	al.,	2006).			
1.2	 Sperm	are	suspended	in	an	agarose	micro	gel	before	being	placed	on	an	
	 agarose	pre‐treated	slide	which	renders	the	sperm	in	a	“suspension‐like	
	 environment”	on	the	slide	(Fernández	et	al.,	2005,	p.	834).			
1.3	 An	acid	solution	is	applied	to	the	agarose/sperm	matrix	to	denature	the	
	 DNA	followed	by	treatment	with	a	lysis	buffer	to	lyse	cell	membranes	and	
	 remove	nuclear	proteins.			
1.4	 As	a	result	a	halo	of	dispersed	DNA	loops	surrounds	the	central	core	which	
	 can	be	viewed	under	bright	field	microscopy	after	staining	the	slides	with	
	 the	Wright’s	stain.		
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1.5		 Sperm	with	intact	DNA	will	show	as	having	large	halos	whilst	those	with	
	 elevated	DNA	fragmentation	will	generate	no	halo	or	at	the	most	a	very	
	 small	halo	(Fernández	et	al.,	2005).		
	  
2	 Pre‐analytic	Process	
2.1	 Semen	Collection	and	Handling		
2.1.1	 Refer	to	LB‐S‐493	for	the	protocol	for	semen	analysis.	
2.1.2	 Semen	samples	will	be	collected	via	masturbation	into	a	60ml	wide‐
	 mouthed	universal	container	and	then	immediately	stored	at	37°C	in	an	
	 incubator	(Memmert	GmbH,	Germany)	for	a	maximum	of	one	hour	(from	
	 production	until	snap	freezing),	to	liquefy.			
2.1.3	 BIOHAZARD:		All	products	or	objects	that	come	in	contact	with	human	or	
	 animal	body	fluids	should	be	handled,	before	and	after	cleaning,	as	if	
	 capable	of	transmitting	infectious	diseases.	Wear	facial	protection,	gloves	
	 and	protective	clothing	
	
2.2		 Semen	Storage	and	Stability	
2.2.1		 Keep	tubes	covered	at	all	times.	
2.2.2		 Do	not	use	samples	that	have	been	stored	at	room	temperature	for	more	
	 than	one	hour.	
	
2.3	 	Reagents	Storage	and	Stability	
The	Halosperm®	G2	test	kit	must	be	stored	at	4oC	and	used	before	the	
specified	expiry	date,	or	destroyed	in	the	Biohazard	bin.	
 
3 Analytical Process  
3.1		 Halosperm®	G2	Assay	
3.1.1	 Equipment	Setup	
1. Check	room	temperature	is	22oC.	
2. At	the	workspace,	half	fill	the	water	bath	with	tap	water.	
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3. As	the	current	temperature	probe	is	not	waterproof,	ensure	the	probe	is	
sealed	in	plastic	and	weighted	down	with	a	brass	key	to	allow	conduction	of	
heat	from	the	water	to	the	probe.			
4. Check	the	temperature	reading	device	is	connected	to	the	probe	and	is	
visible.	
5. Place	the	lid	on	the	water	bath.	
6. Plug	the	water	bath	into	a	power	outlet	and	switch	on.			
7. The	water	bath	should	reach	37oC	(+/‐1oC)	before	it	is	used	for	the	
Halosperm®	G2	assay.	
8. Remove	the	Halosperm®	G2	test	kit	from	the	refrigerator	and	place	this	on	
the	workspace	adjacent	to	the	water	bath.	The	kit	should	be	at	room	
temperature	before	use.	
9. Remove	the	required	number	of	slides	from	the	test	kit	and	place	these	on	
the	bench	in	single	layers	to	allow	the	glass	to	reach	the	room	temperature	
of	22oC.	
10. Remove	from	under	the	bench	the	blue	bag	comprising	of:	4	glass	
containers,	each	with	a	lid	and	housing	one	petri	dish,	one	pipette,	one	
diamond	tip	pen	and	one	stop	watch.	
11. Place	the	required	number	of	glass	containers	and	their	lids	on	a	free	
surface	at	the	workspace.	
12. Two	pipettes	(sizes	20	‐	200L	and	2	‐	20L)	and	stop	watch	should	be	
placed	in	close	proximity	to	the	glass	containers.	
13. Other	items	that	should	be	placed	on	the	free	work	surface	include:	relevant	
pipette	tips	(sizes	20	‐	200L	and	2	‐	20L)	,	1.5ml	eppendorf	tubes,	22	x	
22mm	glass	cover	slips,	a	beaker	containing	2	glass	disposable	pipettes,	
70%	ethanol,	95%	ethanol	and	a	beaker	of	distilled	water,	polystyrene	tray.	
14. If	the	test	is	being	carried	out	in	the	biochemistry	laboratory,	the	metal	
plates	should	be	transferred	from	the	Andrology	fridge	to	the	Biochemistry	
fridge,	both	of	which	are	set	at	4oC.	
3.1.2	 Specimen	Setup	
1. Where	semen	samples	to	be	tested	have	been	previously	frozen	in	Nunc	
tubes,	the	frozen	samples	should	be	removed	from	canister	9	in	the	liquid	
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nitrogen	tank	B	and	placed	in	a	polystyrene	tray	at	the	workspace	to	thaw,	
(approximately	one	hour).	
2. The	required	samples	should	be	cross	checked	with	the	register,	ensuring	
that	the	required	samples	are	removed	from	the	tank.	
3. Once	the	Nunc	tube	has	warmed	slightly	the	lid	should	be	slightly	loosened	
so	that	any	trapped	liquid	nitrogen	is	released	preventing	pressure	build	up	
and	possible	explosion.		
4. The	Nunc	tubes	should	be	arranged	in	the	polystyrene	tray	so	that	the	
patient	sample	that	corresponds	to	the	worksheet	at	#	1	is	placed	to	the	
most	extreme	left	of	the	tray,	several	rows	down	from	the	top.		The	patient	
sample	that	corresponds	to	the	worksheet	at	#	2	should	be	placed	in	the	
space	immediately	to	the	right	of	the	previous	sample	in	the	same	row.		This	
is	done	for	all	patients	so	that	the	patient	samples	are	in	the	same	order	as	
the	corresponding	worksheet	number.			
5. Positive	and	negative	controls	are	frozen	in	straws.		One	positive	and	one	
negative	control	must	be	tested	each	time	a	batch	of	Halosperm®	G2	assays	
are	processed.	
6. The	control	straws	must	be	removed	from,	Canister	2	in	the	liquid	nitrogen	
tank	B	and	placed	on	a	sheet	of	paper	towel	to	thaw	at	the	workspace.			
	
3.1.3	 Paperwork	Setup	
1. A	new	worksheet	should	be	set	up	for	every	batch	of	Halosperm®	G2	
assays	carried	out.	
2. Detail	of	the	Halosperm®	G2	kit	batch	number	and	expiry	date	are	to	be	
recorded	on	the	worksheet.	
3. Detail	of	the	semen	samples	must	be	copied	from	the	Andrology	Halosperm	
register	including	patient’s	first	name	in	small	letters	and	surname	name	in	
capital	letters,	the	patient	ID#	and	the	date	that	the	sample	was	produced.	
4. At	item	‘7’	on	the	worksheet,	record	‘Negative	control’.		
5. At	item	‘8’	on	the	worksheet,	record	‘Positive	control’.		
6. Further	detail	concerning	the	patient,	such	as	sample	number,	days	of	
abstinence,	volume	of	sample,	concentration,	progressive	motility	and	
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morphology	is	obtained	from	the	Powerterm	database.	This	detail	can	be	
completed	during	incubation	periods.	
3.1.4	 Labelling	 	
1. One	eppendorf	tube	should	be	labelled	with	the	corresponding	number	as	
reflected	on	the	worksheet	for	each	patient,	plus	one	tube	labelled	‘7’	and	
one	labelled	‘8’	for	the	negative	and	positive	controls	respectively.	
2. Additionally,	one	eppendorf	tube	to	be	labelled	‘Pos’	and	one	eppendorf	
tube	to	be	labelled	‘Neg’	
3. One	eppendorf	tube	to	be	labelled	‘Neg’	should	be	placed	in	the	polystyrene	
tray	to	collect	the	positive	semen	sample	from	the	straw.	
4. One	eppendorf	tube	to	be	labelled	‘Pos’	should	be	placed	in	the	polystyrene	
tray	to	collect	the	negative	semen	sample	from	the	straw.	
5. Cut	one	end	of	the	positive	control	sample	straw	and	place	the	cut	end	into	
the	eppendorf	tube	housed	in	the	polystyrene	tray	labelled	‘Neg’.		Make	a	
hole	at	the	other	end	and	allow	the	semen	to	flow	into	the	eppendorf	tube.	
6. Clean	the	scissors	by	rinsing	with	water.		
7. Cut	one	end	of	the	negative	control	sample	straw	and	place	the	cut	end	into	
the	eppendorf	tube	housed	in	the	polystyrene	tray	labelled	‘Pos’.		Make	a	
hole	at	the	other	end	and	allow	the	semen	to	flow	into	the	eppendorf	tube.	
8. Clean	the	scissors	by	rinsing	with	water.		
9. Dispose	of	the	straws	into	Biohazard	bin.	
10. Label	each	glass	slide	at	the	clear	end	with	the	diamond	tip	pen	from	1	to	4	
together	with	the	day,	month	and	year	(dd/mm/yyyy).		Ensure	the	slide	is	
the	right	side	up	and	the	well	areas	are	not	touched.		Refer	Appendix	2		
11. Set	pipette	to	50L		
	
3.1.5	 Preparation	of	Slides	
1. Fill	a	beaker	with	800ml	of	boiling	water	and	stand	in	blue	bag.		
Note:	Where	boiling	water	is	collected	from	a	distant	site	(i.e.	kitchen)	
the	beaker	must	be	carried	in	the	insulated	blue	bag	as	a	precaution	
safety	measure.	
	
114	
	
2. Place	the	Agarose	gel	tube	from	the	Halosperm®	G2	kit	into	a	blue	float	
(also	supplied	with	the	kit)	with	the	lid	end	being	exposed	enough	to	hold.	
3. Set	the	stopwatch	for	5	minutes.	
4. The	agarose	gel	tube	in	the	floating	devise	is	then	placed	in	the	beaker	of	
boiling	water	for	5minutes	to	liquefy	the	agarose.	
5. Press	‘start’	on	the	stopwatch	
6. Check	the	water	bath	has	reached	37oC,		
7. Place	one	of	each	labelled	eppendorf	tube	into	a	floating	device	and	then	
place	this	into	the	water	bath.			
8. Eppendorf	tubes	numbered	‘1’	and	‘2’	should	be	placed	in	the	same	floating	
device,	‘3’	and	‘4’	in	the	same	floating	device,	‘5’	and	‘6’	in	the	same	floating	
device	and	‘7’	and	‘8’	in	the	same	floating	device.	At	least	two	thirds	of	the	
tube	should	be	immersed	in	water.	
9. After	5	minutes,	remove	agarose	from	the	boiling	water	and	place	in	the	
polystyrene	tray.	
10. Transfer	50L	of	liquefied	agarose	into	each	eppendorf	tube	floating	in	the	
water	bath.	The	same	pipette	tip	can	be	used	for	transfer	of	agarose	into	all	
eppendorf	tubes.	
11. Set	the	timer	for	5	minutes	and	press	start.		The	agarose	must	be	cooled	to	
37oC	otherwise	the	heat	will	disrupt	the	DNA	integrity.	
12. Remove	and	dispose	of	the	pipette	tip	into	the	biohazard	bin.	
13. Reset	the	pipette	to	25L.	
14. After	this	5	minute	timing	session,	mix	the	semen	sample	by	pumping	the	
pipette	approximately	15	times.	
15. Transfer	25L	of	semen	from	patient	recorded	on	the	worksheet	to	the	
correspondingly	labelled	eppendorf	tube.			
Note:	This	is	a	high	risk	step	as	the	eppendorf	tubes	are	only	labelled	
with	numbers.	Semen	from	the	patient	recorded	on	the	worksheet	at	#1	
must	be	transferred	to	the	eppendorf	tube	in	the	water	bath	labelled	‘1’.		
16. Gently	mix	the	semen	and	agarose	suspension	by	pumping	the	pipette	
approximately	15	times.		Ensure	no	bubbles	are	created.		
17. If	the	semen	sample	is	very	viscose,	visually	check	that	the	semen	is	now	
fully	suspended	in	the	liquefied	agarose.	
18. Discard	the	pipette	tip	into	Biohazard	bin.	
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19. This	is	repeated	for	each	patient,	and	control,	cross	checking	detail	to	
worksheet	numbers	and	eppendorf	numbers.		The	patient	sample	should	be	
placed	into	the	eppendorf	tube	that	corresponds	to	their	worksheet	number		
as	follows:	
Semen	from	the	patient	recorded	on	the	worksheet	at	#2	must	be	transferred	
to	the	eppendorf	tube	in	the	water	bath	labelled	‘2’.	
Semen	from	the	patient	recorded	on	the	worksheet	at	#3	must	be	transferred	
to	the	eppendorf	tube	in	the	water	bath	labelled	‘3’.	
Semen	from	the	patient	recorded	on	the	worksheet	at	#4	must	be	transferred	
to	the	eppendorf	tube	in	the	water	bath	labelled	‘4’.	
Semen	from	the	patient	recorded	on	the	worksheet	at	#5	must	be	transferred	
to	the	eppendorf	tube	in	the	water	bath	labelled	‘5’.	
Semen	from	the	patient	recorded	on	the	worksheet	at	#6	must	be	transferred	
to	the	eppendorf	tube	in	the	water	bath	labelled	‘6’.	
Semen	from	the	negative	control	(eppendorf	tube	labelled	‘Neg’),	recorded	on	
the	worksheet	at	#7	must	be	transferred	to	the	eppendorf	tube	in	the	water	
bath	labelled	‘7’.	
Semen	from	the	positive	control,	(eppendorf	tube	labelled	‘Pos’)recorded	on	
the	worksheet	at	#8	must	be	transferred	to	the	eppendorf	tube	in	the	water	
bath	labelled	‘8’.	
	
20. A	new	pipette	tip	must	be	used	for	each	semen	sample.	
21. Set	the	pipette	to	8L.	
22. Place	the	glass	slides	in	order	from	1	to	4	on	the	bench,	in	preparation	of	
placing	the	cell	suspension	on	the	slides.	
23. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘1’	onto	slide	
labelled	‘1’	in	the	centre	of	the	well	area	labelled	‘S’	and	place	a	cover	slip	
over	this	immediately.	Discard	the	pipette	tip	into	biohazard	bin	and	collect	
a	new	tip.	
24. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘2’	onto	slide	
labelled	‘1’	in	the	centre	of	the	well	area	labelled	‘C’	and	place	a	cover	slip	
over	this	immediately.	
Discard	the	pipette	tip	into	biohazard	bin	and	collect	a	new	tip.	
25. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘3’	onto	slide	
labelled	‘2’	in	the	centre	of	the	well	area	labelled	‘S’	and	place	a	cover	slip	
over	this	immediately.	Discard	the	pipette	tip	into	biohazard	bin	and	collect	
a	new	tip.	
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26. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘4’	onto	slide	
labelled	‘2’	in	the	centre	of	the	well	area	labelled	‘C’	and	place	a	cover	slip	
over	this	immediately.	Discard	the	pipette	tip	into	biohazard	bin	and	collect	
a	new	tip.	
27. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘5’	onto	slide	
labelled	‘3’	in	the	centre	of	the	well	area	labelled	‘S’	and	place	a	cover	slip	
over	this	immediately.	Discard	the	pipette	tip	into	biohazard	bin	and	collect	
a	new	tip.	
28. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘6’	onto	slide	
labelled	‘3’	in	the	centre	of	the	well	area	labelled	‘C’	and	place	a	cover	slip	
over	this	immediately.	Discard	the	pipette	tip	into	biohazard	bin	and	collect	
a	new	tip.	
29. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘7’	onto	slide	
labelled	‘4’	in	the	centre	of	the	well	area	labelled	‘S’	and	place	a	cover	slip	
over	this	immediately.	Discard	the	pipette	tip	into	biohazard	bin	and	collect	
a	new	tip.	
30. Place	8L	of	cell	suspension	from	eppendorf	tube	labelled	‘8’	onto	slide	
labelled	‘4’	in	the	centre	of	the	well	area	labelled	‘C’	and	place	a	cover	slip	
over	this	immediately.	Discard	the	pipette	tip	into	biohazard	bin	and	collect	
a	new	tip.	
31. Remove	the	metal	plates	from	the	fridge	and	place	each	slide	onto	a	metal	
plate.		Two	slides	and	be	placed	onto	one	metal	plate.	The	slide	must	have	
full	contact	with	the	metal	plate	and	not	be	placed	over	the	holes	in	the	
plate.	
32. Return	the	metal	plates	to	the	same	fridge.	
33. Set	the	stop	watch	for	5	minutes	and	press	start.		Incubating	in	the	fridge	at	
4oC	for	5	minutes	will	solidify	the	agarose.		
34. After	5	minutes,	remove	the	slides	from	the	fridge	and	gently	remove	the	
cover	slips	by	sliding	the	cover	slip	to	the	nearest	long	edge	of	the	slide	to	
avoid	contamination.	
35. Place	the	slide	in	the	horizontal	position	on	the	petri	dish	inside	the	glass	
container.	
36. Place	the	lid	on	the	container	immediately	
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37. Dispose	of	the	cover	slips	into	the	Biohazard	bin.	
	
3.1.6	 Sample	Processing	
1. Set	the	stopwatch	to	7	minutes.	
2. Add	4	drops	of	solution	1	(checking	the	solution	number	on	the	bottle	
before	use)	from	the	Halosperm®	G2	kit	to	each	well	to	full	cover	the	
solidified	suspension.	
3. Press	‘start’	on	the	stop	watch	when	the	first	half	of	the	slides	have	been	
covered	with	solution	1.	
4. Immediately	place	the	lids	on	each	glass	container	when	application	of	
solution	1	is	complete	for	all	slides.	
5. Place	the	metal	trays	back	in	the	Andrology	fridge.	
6. After	7	minutes,	remove	the	glass	lids	and	drain	each	slide	by	tapping	the	
long	edge	of	the	slide	against	the	petri	dish	and	then	returning	the	slide	to	
the	horizontal	position	on	the	petri	dish	inside	the	glass	container.	
7. Set	the	stop	watch	for	20minutes.	
8. Add	5	drops	of	solution	2	(checking	the	solution	number	on	the	bottle	
before	use)	from	the	Halosperm®	G2	kit	to	each	well	to	fully	immerse	the	
solidified	suspension.	
9. Press	‘start’	on	the	stop	watch	when	the	first	half	of	the	slides	have	been	
covered	with	solution	2.	
10. Immediately	place	the	lids	on	each	glass	container	when	application	of	
solution	2	is	complete	for	all	slides.	
11. After	20	minutes,	remove	the	glass	lids	and	drain	each	slide	by	tapping	the	
long	edge	of	the	slide	against	the	petri	dish	and	then	returning	the	slide	to	
the	horizontal	position	on	the	petri	dish	inside	the	glass	container.	
12. Set	the	stop	watch	for	5minutes.	
13. Using	a	glass,	disposable	pipette,	wash	each	slide	with	an	abundant	amount	
of	distilled	water.	
14. Press	‘start’	on	the	stop	watch	when	the	first	half	of	the	slides	have	been	
covered	with	distilled	water.	
15. Immediately	place	the	lids	on	each	glass	container	when	application	of	the	
distilled	water	is	complete	for	all	slides.	
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16. After	5	minutes,	remove	the	glass	lids	and	drain	each	slide	by	tapping	the	
long	edge	of	the	slide	against	the	petri	dish	and	then	returning	the	slide	to	
the	horizontal	position	on	the	petri	dish	inside	the	glass	container.	
17. Set	the	stop	watch	for	2minutes.	
18. Using	the	same	pipette	as	before,	dehydrate	the	solidified	suspension	by	
flooding	with	70%	ethanol	for	2	minutes	
19. Press	‘start’	on	the	stop	watch	when	the	first	half	of	the	slides	have	been	
covered	with	70%	ethanol.	
20. Immediately	place	the	lids	on	each	glass	container	when	application	of	the	
70%	ethanol	is	complete	for	all	slides.		
Note:	This	must	be	done	quickly	to	prevent	the	ethanol	from	evaporating.	
21. After	2	minutes,	remove	the	glass	lids	and	drain	each	slide	by	tapping	the	
long	edge	of	the	slide	against	the	petri	dish	and	then	returning	the	slide	to	
the	horizontal	position	on	the	petri	dish	inside	the	glass	container.	
22. Set	the	stop	watch	for	2minutes.	
23. Using	a	new	glass	disposable	pipette	,	dehydrate	the	solidified	suspension	
by	flooding	with	95%	ethanol	for	2	minutes	
24. Press	‘start’	on	the	stop	watch	when	the	first	half	of	the	slides	have	been	
covered	with	95%	ethanol.	
25. Immediately	place	the	lids	on	each	glass	container	when	application	of	the	
95%	ethanol	is	complete	for	all	slides.	
Note:	This	must	be	done	quickly	to	prevent	the	ethanol	from	evaporating.	
26. After	2	minutes,	remove	the	glass	lids	and	drain	each	slide	by	tapping	the	
long	edge	of	the	slide	against	the	petri	dish	and	then	returning	the	slide	to	
the	horizontal	position	on	the	petri	dish	inside	the	glass	container.	
27. Wipe	any	excess	liquid	with	a	paper	towel	from	the	long	edge	of	each	slide,	
being	careful	not	to	touch	the	wells.	
28. Stand	the	slides	along	their	long	edge	against	a	glass	container	which	is	
resting	on	a	paper	towel.		Leave	these	to	air	dry	(approximately	10‐15	
minutes	or	until	the	slide	is	visibly	dry).	
29. Place	the	lids	back	on	the	glass	containers.	
	
3.1.7	 Staining		
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1. Place	each	slide	in	the	horizontal	position	on	the	petri	dish	inside	the	glass	
container.	
2. Set	the	stop	watch	for	7minutes.	
3. Add	5	drops	of	solution	3	from	the	Halosperm®	G2	kit	(checking	the	
solution	number	on	the	bottle	before	use)	to	each	well	to	fully	immerse	the	
solidified	suspension.	
4. Press	‘start’	on	the	stop	watch	when	the	first	half	of	the	slides	have	been	
covered	with	solution	3.	
5. Immediately	place	the	lids	on	each	glass	container	when	application	of	
solution	3	is	complete	for	all	slides.	
6. After	7	minutes,	remove	the	glass	lids	and	drain	each	slide	by	tapping	the	
long	edge	of	the	slide	against	the	petri	dish	and	then	returning	the	slide	to	
the	horizontal	position	on	the	petri	dish	inside	the	glass	container.	
7. Set	the	stop	watch	for	7minutes.	
8. Add	5	drops	of	solution	4	from	the	Halosperm®	G2	kit	(checking	the	
solution	number	on	the	bottle	before	use)	to	each	well	to	fully	immerse	the	
solidified	suspension.	
9. Press	‘start’	on	the	stop	watch	when	the	first	half	of	the	slides	have	been	
covered	with	solution	4.	
10. Immediately	place	the	lids	on	each	glass	container	when	application	of	
solution	4	is	complete	for	all	slides.	
11. After	7	minutes,	remove	the	glass	lids	and	drain	each	slide	by	tapping	the	
long	edge	of	the	slide	against	the	petri	dish.	
12. Wipe	any	excess	liquid	with	a	paper	towel	from	the	long	edge	of	each	slide,	
being	careful	not	to	touch	the	wells.	
13. Stand	the	slides	along	their	long	edge	against	a	glass	container	which	is	
resting	on	a	paper	towel.		Leave	these	to	air	dry	(approximately	10‐15	
minutes	or	until	the	slide	is	visibly	dry).	
14. Place	the	lids	back	on	the	glass	containers.	
	
3.1.8	Clean	up	
The	clean‐up	process	can	be	carried	out	as	each	stage	is	completed,	however	the	
eppendorf	tubes	from	the	water	bath	must	not	be	discarded	until	visualization	of	
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the	samples	is	complete	and	it	has	been	confirmed	that	the	assay	has	been	
successful.	
3.1.9	Visualization	
With	a	bright	field	microscope	and	using	an	imaginary	grid	starting	at	the	west	
most	point	of	the	well,	count	individual	sperm	as	fragmented	or	non‐fragmented	
(according	to	Appendix	2)	moving	the	stage	in	the	forward	position	until	the	edge	
of	the	well	is	reached.		Move	the	stage	to	the	left	and	continue	counting	whilst	
moving	the	stage	in	the	backward	position	until	the	edge	of	the	well	is	reached.		
Move	the	stage	further	to	the	left	and	continue	counting	whilst	moving	the	stage	in	
the	forward	position	until	the	edge	of	the	well	is	reached.		Continue	until	a	total	of	
300	sperms	are	counted.	 	
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5 Appendices 
	Appendix	1	–	Photograph	of	Halosperm®	Slide	with	one	well	identified	
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Appendix	2	–	Sperm	DNA	Fragmentation	Classification	
	
	
 
 
 
 
 
